<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Chinese herbal medicine for menopausal symptoms - Zhu, X - 2016 | Cochrane Library</title> <meta content="Chinese herbal medicine for menopausal symptoms - Zhu, X - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009023.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Chinese herbal medicine for menopausal symptoms - Zhu, X - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009023.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009023.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Chinese herbal medicine for menopausal symptoms" name="citation_title"/> <meta content="Xiaoshu Zhu" name="citation_author"/> <meta content="Western Sydney University" name="citation_author_institution"/> <meta content="x.zhu@uws.edu.au" name="citation_author_email"/> <meta content="Yuklan Liew" name="citation_author"/> <meta content="Herbal Medicines Research and Education Centre, Sydney University" name="citation_author_institution"/> <meta content="Zhao Lan Liu" name="citation_author"/> <meta content="Beijing University of Chinese Medicine" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD009023.pub2" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/03/15" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009023.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009023.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009023.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Drugs, Chinese Herbal [adverse effects, *therapeutic use]; Estazolam [therapeutic use]; Fluoxetine [therapeutic use]; Hormone Replacement Therapy; Hot Flashes [drug therapy]; Menopause; Quality of Life; Randomized Controlled Trials as Topic; Sweating [*drug effects]; Time Factors" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009023.pub2&amp;doi=10.1002/14651858.CD009023.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="cdmLYOAV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009023\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009023\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","hr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009023.pub2",title:"Chinese herbal medicine for menopausal symptoms",firstPublishedDate:"Mar 15, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=cdmLYOAV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009023.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009023.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009023.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009023.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009023.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009023.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009023.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009023.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009023.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009023.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6569 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009023.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-sec-0123"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-sec-0059"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-sec-0117"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/appendices#CD009023-sec-0128"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/table_n/CD009023StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/table_n/CD009023StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Chinese herbal medicine for menopausal symptoms</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/information#CD009023-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Xiaoshu Zhu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/information#CD009023-cr-0003">Yuklan Liew</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009023.pub2/information#CD009023-cr-0004">Zhao Lan Liu</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/information/en#CD009023-sec-0139">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 15 March 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009023.pub2">https://doi.org/10.1002/14651858.CD009023.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009023-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009023-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009023-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009023-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009023-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009023-abs-0001" lang="en"> <section id="CD009023-sec-0001"> <h3 class="title" id="CD009023-sec-0001">Background</h3> <p>Chinese herbal medicine (CHM) usage is expected to increase as women suffering from menopausal symptoms are seeking alternative therapy due to concerns from the adverse effects (AEs) associated with hormone therapy (HT). Scientific evidence for their effectiveness and safety is needed. </p> </section> <section id="CD009023-sec-0002"> <h3 class="title" id="CD009023-sec-0002">Objectives</h3> <p>To evaluate the effectiveness and safety of CHM in the treatment of menopausal symptoms.</p> </section> <section id="CD009023-sec-0003"> <h3 class="title" id="CD009023-sec-0003">Search methods</h3> <p>We searched the Gynaecology and Fertility Group's Specialised Register of controlled trials, Cochrane Central Register of Controlled Trials (CENTRAL; 2015, Issue 3), MEDLINE, Embase, CINAHL, AMED, and PsycINFO (from inception to March 2015). Others included Current Control Trials, Citation Indexes, conference abstracts in the ISI Web of Knowledge, LILACS database, PubMed, OpenSIGLE database, and China National Knowledge Infrastructure database (CNKI, 1999 to 2015). Other resources included reference lists of articles as well as direct contact with authors. </p> </section> <section id="CD009023-sec-0004"> <h3 class="title" id="CD009023-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) comparing the effectiveness of CHM with placebo, HT, pharmaceutical drugs, acupuncture, or another CHM formula in women over 18 years of age, and suffering from menopausal symptoms. </p> </section> <section id="CD009023-sec-0005"> <h3 class="title" id="CD009023-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed 864 studies for eligibility. Data extractions were performed by them with disagreements resolved through group discussion and clarification of data or direct contact with the study authors. Data analyses were performed in accordance with Cochrane Collaboration guidelines. </p> </section> <section id="CD009023-sec-0006"> <h3 class="title" id="CD009023-sec-0006">Main results</h3> <p>We included 22 RCTs (2902 women). Participants were from different ethnic backgrounds with the majority of Chinese origin. </p> <p>When CHM was compared with placebo (eight RCTs), there was little or no evidence of a difference between the groups for the following pooled outcomes: hot flushes per day (MD 0.00, 95% CI ‐0.88 to 0.89; 2 trials, 199 women; moderate quality evidence); hot flushes per day assessed by an overall hot flush score in which a difference of one point equates to one mild hot flush per day (MD ‐0.81 points, 95% CI ‐2.08 to 0.45; 3 RCTs, 263 women; low quality evidence); and overall vasomotor symptoms per month measured by the Menopause‐Specific Quality of Life questionnaire (MENQOL, scale 0 to 6) (MD ‐0.42 points; 95% CI ‐1.52 to 0.68; 3 RCTs, 256 women; low quality evidence). </p> <p>In addition, results from individual studies suggested there was no evidence of a difference between the groups for daily hot flushes assessed by severity (MD ‐0.70 points, 95% CI ‐1.00, ‐0.40; 1 RCT, 108 women; moderate quality evidence); or overall monthly hot flushes scores (MD ‐2.80 points, 95% CI ‐8.93 to 3.33; 1 RCT, 84 women; very low quality evidence); or overall daily night sweats scores (MD 0.07 points, 95% CI ‐0.19 to 0.33, 1 RCT, 64 women; low quality evidence); or overall monthly night sweats scores (MD 1.30 points, 95% CI ‐1.76 to 4.36, 1 RCT, 84 women; very low quality evidence). However one study using the Kupperman Index reported that overall monthly vasomotor symptom scores were lower in the CHM group (MD ‐4.79 points, 95% CI ‐5.52 to ‐4.06; 1 RCT, 69 women; low quality evidence). </p> <p>When CHM was compared with hormone therapy (HT) (10 RCTs), only two RCTs reported monthly vasomotor symptoms using MENQOL. It was uncertain whether CHM reduces vasomotor symptoms (MD 0.47 points, 95% CI ‐0.50 to 1.44; 2 RCTs, 127 women; very low quality evidence). </p> <p>Adverse effects were not fully reported in the included studies. Adverse events reported by women taking CHM included mild diarrhoea, breast tenderness, gastric discomfort and an unpleasant taste. Effects were inconclusive because of imprecise estimates of effects: CHM versus placebo (RR 1.51; 95% CI 0.69 to 3.33; 7 trials, 705 women; I² = 40%); CHM versus HT (RR 0.96; 95% CI 0.66 to 1.39; 2 RCTs, 864 women; I² = 0%); and CHM versus specific conventional medications (such as Fluoxetine and Estazolam) (RR 0.20; 95% CI 0.03 to 1.17; 2 RCTs, 139 women; I² = 61%). </p> </section> <section id="CD009023-sec-0007"> <h3 class="title" id="CD009023-sec-0007">Authors' conclusions</h3> <p>We found insufficient evidence that Chinese herbal medicines were any more or less effective than placebo or HT for the relief of vasomotor symptoms. Effects on safety were inconclusive. The quality of the evidence ranged from very low to moderate; there is a need for well‐designed randomised controlled studies. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009023-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009023-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009023-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009023-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009023-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD009023-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD009023-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009023-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009023-abs-0003" lang="en"> <h3>Title: Chinese herbal medicines for menopausal symptoms</h3> <p><b>Review Question:</b> Are Chinese herbal medicines effective and safe for relieving menopausal symptoms? </p> <p><b>Background:</b> Menopause usually takes place when a woman is around 51 years of age. Women can experience symptoms such as hot flushes, sweats, poor sleep, joint pains, anxiousness, dry skin and vagina when the organs which produce female hormones slow down. Usually hormone therapy (HT) is prescribed to reduce the symptoms. </p> <p>Due to concerns on long term use of HT resulting in adverse effects, women have been looking for alternative treatments to relieve their symptoms. Chinese herbal medicines (CHM) is one of the popular choices. Although CHM has been used for a very long time clinically, its effectiveness and long‐term safety remained unanswered from a scientific perspective. </p> <p><b>Study characteristics:</b> This review examined 22 randomised clinical trials where 2902 women took part in the studies; 1499 in the CHM group and 1403 in the control group which might include a placebo (non‐active compound made to look, taste and smell the same as the study compound) or a drug or HT or another CHM formula (different from the one being tested). Most of the studies had a trial period for 12 weeks. The data are current to March 2015. </p> <p><b>Key results:</b> We found insufficient evidence that CHM were any more or less effective than placebo or HT for the relief of vasomotor symptoms. Adverse effects were not well reported, some women taking CHM reported mild diarrhoea, breast tenderness, gastric discomfort and an unpleasant taste. Effects on safety were inconclusive. </p> <p><b>Quality of the evidence:</b> The quality of the evidence ranged from very low to moderate. The studies did not produce good quality evidence to allow the authors to draw a conclusive statement regarding the effectiveness or safety of CHM. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009023-sec-0123" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009023-sec-0123"></div> <h3 class="title" id="CD009023-sec-0124">Implications for practice</h3> <section id="CD009023-sec-0124"> <p>Based on the findings, this review was unable to draw firm conclusions about the effectiveness and safety of CHM for menopausal symptoms due to inadequate quality of the research evidence. </p> </section> <h3 class="title" id="CD009023-sec-0125">Implications for research</h3> <section id="CD009023-sec-0125"> <p>In view of the heterogeneity across the included studies, inadequate reporting of study methods, blinding of relevant personnel, and the wide range of outcome measurements, there is a need for conducting further research on CHM for menopausal symptoms. Recommendations for further research include the improvement of the quality of study designs including allocation concealment, randomisation and participants' withdrawals. Consideration of measuring relevant symptoms as the whole‐person when designing trials of CHM should also be given. The fundamental tradition philosophies should be also considered when rigorous scientific research design is implemented in order to reflect the true clinical practice as well as long‐term positive empirical clinical response. </p> <p>Herb extracts are more practical for a CHM trial than herbs in a raw form. Furthermore, a standardised formulation should only be tested in consideration of relevant Chinese medicine diagnostic pattern(s) for its validity. In addition, greater consistency in outcome measures is warranted. </p> <p>It would be interesting to look into the potential mechanisms of CHM on menopausal symptoms, given that many studies reported the relevant data. As a safety guidance, it is important to understand if CHM may influence the hormone profiles in a similar manner as HT does, or whether it is different from the HT pathways. Further studies on CHM pharmacological mechanisms are warranted as this will provide comfort on the use of CHM as an alternative in comparison with the known adverse effects of HT. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009023-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009023-sec-0022"></div> <div class="table" id="CD009023-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Chinese herbal medicine (CHM) compared with placebo for menopausal symptoms</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Findings of Effectiveness (Primary outcome)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> women with menopausal symptoms<br/> <b>Settings:</b> Community<br/> <b>Intervention:</b> CHM<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Assumed risk</b> </p> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> <p><b>CHM compared to placebo</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>Frequency of hot flushes measured in a diary (daily)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean</p> <p>frequency of hot flushes</p> <p>in the control groups</p> <p>ranged across control groups from<br/> ‐2.81 to 2.4 points in a diary </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean frequency of hot flushes was 0 points flushes per day more in the CHM groups than in placebo group (0.88 to 0.89 points more flushes) in a diary. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>199<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝</p> <p>MODERATE <sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A lower score means less bothersome hot flushes</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>Severity of hot flushes measured in a diary (daily)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean severity of hot flushes in the control groups was<br/> 2.3 points in a diary. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean severity of hot flushes was 0.70 points lower in the CHM group than in the placebo group (1.00 lower to 0.40 lower) in a diary. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>108<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝</p> <p>MODERATE <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A lower score means less bothersome hot flushes</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>Overall scores of hot flushes in a diary (daily)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall hot flush scores (frequency and severity)</p> <p>in the control groups</p> <p>ranged across control groups from<br/> ‐5.15 to 7.0 scores in a diary </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall hot flush scores (frequency and severity) in the CHM groups was 0.81 scores lower (2.08 lower to 0.45 higher) in a diary. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>263<br/> (3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW<sup>1 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A lower score means less bothersome hot flushes</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>Overall scores of hot flushes in a diary (monthly)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall vasomotor symptoms (hot flushes/night sweats)</p> <p>in the control groups</p> <p>was 7.9 points</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall vasomotor symptoms (hot flushes/night sweats) was 2.8 points lower in the CHM group than in placebo group (8.93 fewer to 3.33 more) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p>VERY LOW <sup>4,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A lower score means less bothersome hot flushes</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>Overall night sweats in a diary (daily)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall daily night sweat score (frequency and severity)</p> <p>in the control groups</p> <p>was 0.42 in a diary</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall daily night sweat score (frequency and severity) in the CHM group was 0.07 higher (0.19 lower to 0.33 higher) than in placebo in a diary </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p>LOW <sup>1,6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A lower score means less bothersome night sweats</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>Overall scores of night sweats in a diary (monthly)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall monthly night sweats (frequency and severity)</p> <p>in the control groups</p> <p>was 1.9 points</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall monthly night sweats (frequency and severity) was 1.3 points higher in the CHM group (1.76 fewer to 4.36 more) than in placebo </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p>VERY LOW <sup>4,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A lower score means less bothersome night sweats</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>measured by the Kupperman Index (KI, monthly)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean vasomotor symptom scores</p> <p>in the control groups</p> <p>was 6.81 scores</p> <p>on an 11‐item questionnaire</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean vasomotor symptom scores was<br/> 4.79 points lower in the CHM group (5.52 lower to 4.06 lower) than in placebo, on an 11‐item questionnaire. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p>LOW <sup>2, 7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>KI is a 11‐item questionnaire with scale from 0 to 3. A lower score means fewer symptoms.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vasomotor Symptoms<br/> <b>measured by Menopause Specific Quality of Life Questionnaire (MENQOL, monthly)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean vasomotor symptom scores</p> <p>in the control groups</p> <p>ranged across control groups from<br/> 1.73 to 7.9 points on </p> <p>an 29‐item questionnaire</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean vasomotor symptom scores was 0.42 points lower in the CHM group (1.52 lower to 0.68 higher) than in placebo, on an 29‐item questionnaire. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MENQOL is a 29‐item questionnaire with scale from 0 to 6. A lower score means fewer symptoms. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse Effects</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>31 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>47 per 1000<br/> (22 to 104) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.51<br/> (0.69 to 3.33) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>705<br/> (7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p>VERY LOW <sup>8 9 10</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the assumed risk is the median control group risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).<br/> CI: Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level due to serious imprecision (small sample size; confidence interval suggests both benefit and harm). </p> <p><sup>2</sup>Downgraded one level due to serious imprecision (small sample size). </p> <p><sup>3</sup>Downgraded one level due to serious risk of bias (high drop‐off and ITT was not or was not properly implemented in one of the three studies, Xia 2012). </p> <p><sup>4</sup>Downgraded one level due to serious risk of bias (blinding of outcome assessors unclear and high likelihood of attrition bias). </p> <p><sup>5</sup>Downgraded two levels due to very serious imprecision (small sample size; very wide confidence interval, suggesting appreciable benefit and harm). </p> <p><sup>6</sup>Downgraded one level due to serious risk of bias (high likelihood of attrition bias). </p> <p><sup>7</sup>Downgraded one level due to serious risk of bias (allocation concealment and blinding of outcome assessors unclear). </p> <p><sup>8</sup>Downgraded one level because of serious inconsistency (the directions of effects were inconsistent). </p> <p><sup>9</sup>Downgraded one level due to serious risk of bias (allocation concealment and blinding of outcome assessors unclear, high likelihood of attrition bias). </p> <p><sup>10</sup>Downgraded one level due to very serious imprecision (very wide confidence interval). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009023-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">CHM compared with HT for menopausal symptoms</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Findings of Effectiveness (Primary Outcome)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Women with menopausal symptoms<br/> <b>Settings:</b> Outpatients<br/> <b>Intervention:</b> CHM<br/> <b>Comparison:</b> HT </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes<sup>a</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> <p><b> scores/values</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding</b> </p> <p><b> scores/values</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> HT</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> CHM</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vasomotor Symptoms <b>measured by Menopause Specific Quality of Life Questionnaire (MENQOL, monthly)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean vasomotor symptoms</p> <p>in the control groups</p> <p>ranged across control groups from<br/> 0.36 to 0.45 points, on an 0‐29 questionnaire scale </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean vasomotor symptoms was<br/> 0.47 points higher in the CHM group than in HT<br/> (0.5 lower to 1.44 higher), on an 0‐29 questionnaire scale. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>127<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.47 (‐0.50 to 1.44)</p> <p>MENQOL a 29‐item questionnaire with scale from 0 to 6. A lower score means fewer symptoms.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse Effects</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>60 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>57 per 1000<br/> (40 to 83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.96<br/> (0.66 to 1.39) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>864<br/> (6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Symptoms reported included mild diarrhoea, breast tenderness, gastric discomfort and an unpleasant taste </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).<br/> CI<b>:</b> Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> None of the included studies in this comparison assessed the following primary outcomes: frequency of daily hot flushes; frequency of daily night sweats; severity of daily hot flushes; severity of daily night sweats; overall scores of daily hot flushes; overall scores of daily night sweats measured in a diary. </p> <p><sup>1</sup>Downgraded one level due to serious imprecision (small sample size; confidence interval suggests both benefit and harm). </p> <p><sup>2</sup> Downgraded two levels due to very serious risk of bias (sequence generation, allocation concealment and blinding of outcome assessors unclear; study participants and personnel not blinded; outcome data incomplete). </p> <p><sup>3</sup>Downgraded one level due to serious imprecision (very wide confidence interval). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009023-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009023-sec-0023"></div> <section id="CD009023-sec-0024"> <h3 class="title" id="CD009023-sec-0024">Description of the condition</h3> <p>Menopause is defined as the permanent cessation of menses, usually signalling the end of a woman’s reproductive years (<a href="./references#CD009023-bbs2-0044" title="GreendaleGA , LeeNP , ArriolaER . The menopause. Lancet1999;353(9152):571‐80. ">Greendale 1999</a>). It is said to have occurred after 12 months of amenorrhoea (the absence of menstrual periods), therefore the time of the final menses can only be determined retrospectively. Menopause may occur naturally as the result of ageing or as a consequence of the following: surgical removal of ovaries, or as a result of radiation, or chemotherapy (<a href="./references#CD009023-bbs2-0041" title="DodinS , BlanchetC , MarcI , ErnstE , WuT , VaillancourtC , PaquetteJ , MaunsellE . Acupuncture for menopausal hot flushes. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD007410] ">Dodin 2013</a>). The mean age of natural menopause is 51 years (<a href="./references#CD009023-bbs2-0043" title="GoldE , BrombergerJ , CrawfordS . Factors associated with age at natural menopause in a multiethnic sample of midlife women. American Journal of Epidemiology2001;153(9):865‐74. ">Gold 2001</a>; <a href="./references#CD009023-bbs2-0044" title="GreendaleGA , LeeNP , ArriolaER . The menopause. Lancet1999;353(9152):571‐80. ">Greendale 1999</a>; <a href="./references#CD009023-bbs2-0062" title="NelsonH . Menopause. Lancet2008;371:60‐70. ">Nelson 2008</a>) with most women experiencing menopause with a range of 40 and 58 years of age (<a href="./references#CD009023-bbs2-0064" title="NIH . NIH State‐of‐the‐Science Conference Statement on Management of Menopause‐Related Symptoms. NIH Consensus State Science Statements2005;22(1):1‐38. ">NIH 2005</a>). Age at menopause may be affected by various factors such as smoking, socioeconomic status, age at menarche (first menstrual period), parity, previous oral contraceptive use, body‐mass index (BMI), ethnic origin, and family history (<a href="./references#CD009023-bbs2-0062" title="NelsonH . Menopause. Lancet2008;371:60‐70. ">Nelson 2008</a>).   </p> <p>Women experience menopause differently; vasomotor complaints such as hot flushes and perspiration being the most commonly reported in the USA and UK, whereas joint pain is a complaint prevalent amongst Asian women (<a href="./references#CD009023-bbs2-0035" title="Castelo‐BrancoC , PalaciosS , MostajoD , TobarC , vonHeldeS . Menopausal transition in Movima women, a Bolivian Native‐American. Maturitas2005;51(4):380‐5. ">Castel‐Branco 2005</a>; <a href="./references#CD009023-bbs2-0037" title="ChimH , TanBH , AngCC , ChewEM , ChongYS , SawSM . The prevalence of menopausal symptoms in a community in Singapore. Maturitas2002;41(4):275‐82. ">Chim 2002</a>; <a href="./references#CD009023-bbs2-0040" title="DennersteinL , LehertP . Women's sexual functioning, lifestyle, mid‐age, and menopause in 12 European countries. Menopause2004;11(6 Pt 2):778‐85. ">Dennerstein 2004</a>; <a href="./references#CD009023-bbs2-0073" title="SinghA , KaurS , WaliaI . A historical perspective on menopause and menopausal age. Bulletin of the Indian Institute of History of Medicine (Hyderabad)2002;32(2):121‐35. ">Singh 2002</a>). Other common symptoms include loss of libido, dryness and thinning of the skin and vaginal wall, mood swings and depression, osteoporosis, and insomnia. Variations in these clinical symptoms may occur across ethnic groups (<a href="./references#CD009023-bbs2-0030" title="AvisNE , StellatoR , CrawfordS . Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Social Science and Medicine2001;52(3):345‐56. ">Avis 2001</a>; <a href="./references#CD009023-bbs2-0042" title="GellerS , StudeeL . Contemporary alternatives to plant estrogens for menopause. Maturitas2006;55(Supp1):3‐13. ">Geller 2006</a>; <a href="./references#CD009023-bbs2-0046" title="HainesCJ , XingSM , ParkKH , HolinkaCF , AusmanasMK . Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan‐Asia Menopause (PAM) study. Maturitas2005;52(3‐4):264‐76. ">Haines 2005</a>; <a href="./references#CD009023-bbs2-0062" title="NelsonH . Menopause. Lancet2008;371:60‐70. ">Nelson 2008</a>). Symptoms also tend to fluctuate and their severity varies greatly between individuals, ranging from a mere discomfort to severe distress with substantial reduction in the quality of life (<a href="./references#CD009023-bbs2-0057" title="MarjoribanksJ , FarquharC , RobertsH , LethabyA . Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews2012, Issue 7. [DOI: 10.1002/14651858.CD004143] ">Marjoribanks 2012</a>). The average duration of menopausal symptoms is three and a half years (<a href="./references#CD009023-bbs2-0059" title="McKinlaySM , BrambillaDJ , PosnerJG . The normal menopause transition. American Journal of Human Biology2006;4(1):37‐46. ">McKinlay 2006</a>), however it can range from five months to 10 years (<a href="./references#CD009023-bbs2-0054" title="LeachM J , MooreV . Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD007244] ">Leach 2012</a>). </p> <p>Natural menopause occurs when the ovaries no longer produce eggs (ovulation), and therefore the amounts of the hormones progesterone and oestrogen present in the body decrease significantly. </p> </section> <section id="CD009023-sec-0025"> <h3 class="title" id="CD009023-sec-0025">Description of the intervention</h3> <p>In many countries, women are actively seeking alternative approaches to reduce their menopausal symptoms (<a href="./references#CD009023-bbs2-0031" title="BairYA , GoldEB , ZhangG , RasorN , UttsJ , UpchurchD , et al. Use of complementary and alternative medicine during the menopause transition: longitudinal results from the Study of Women's Health Across the Nation [Bair YA1, Gold EB, Zhang G, Rasor N, Utts J, Upchurch DM, Chyu L, Greendale GA, Sternfeld B, Adler SR.Author information]. Menopause2008;15(1):32‐43. ">Bair 2008</a>; <a href="./references#CD009023-bbs2-0032" title="BiddleRA , WilkinsonJM , SimpsonMD . Do Australian women use complementary medicines for reproductive conditions?. Australian Journal of Pharmacy2003;22(1):52‐6. ">Biddle 2003</a>; <a href="./references#CD009023-bbs2-0036" title="ChenLC , WangBR , ChenIC , ShaoCH . Use of Chinese herbal medicine among menopausal women in Taiwan. International Journal of Gynecology and Obstetrics2010;109(1):63‐6. ">Chen 2010</a>; <a href="./references#CD009023-bbs2-0060" title="MichelleP , WarrenMD . Use of alternative therapies in menopause. Best Practice &amp; Research Clinical Obstetrics and Gynaecology2002;16(3):411‐48. ">Michelle 2002</a>; <a href="./references#CD009023-bbs2-0063" title="NewtonKM , BuistDSM , KeenanNL , AndersonLA , LaCroixAZ . Use of alternative therapies for menopause symptoms: results of a population‐based sample. Obstetrics and Gynecology2002;100(1):18‐25. ">Newton 2002</a>). These include vitamins and minerals, plant‐derived dietary supplements, meditation, and traditional Chinese medicine (TCM). TCM is one of the most popular alternative and complementary therapies (<a href="./references#CD009023-bbs2-0077" title="TindleHA , DavisRB , PhillipsRS , EisenbergDM . Trends in use of complementary and alternative medicine by US adults: 1997‐2002. Alternative Therapies in Health and Medicine2005;Jan‐Feb;11(1):42‐9. ">Tindle 2005</a>; <a href="./references#CD009023-bbs2-0080" title="XueCC , ZhangAL , LinV , CostaCDA , StoryDF . Complementary and alternative medicine use in Australia: a national population‐based survey. Journal of Alternative and Complementary Medicine2007;13(6):643‐50. ">Xue 2007</a>), with a history of practice exceeding 2000 years. It offers a clear and systematic approach to the management of menopausal symptoms (<a href="./references#CD009023-bbs2-0072" title="ScheidV . Traditional Chinese medicine‐what are we investigating? The case of menopause. Complementary Therapies in Medicine2007;15:54‐68. ">Scheid 2007</a>). Its therapies, including the use of Chinese herbal medicine (CHM), acupuncture, and specific diets and exercises, are commonly used to relieve menopausal symptoms in Eastern countries (<a href="./references#CD009023-bbs2-0036" title="ChenLC , WangBR , ChenIC , ShaoCH . Use of Chinese herbal medicine among menopausal women in Taiwan. International Journal of Gynecology and Obstetrics2010;109(1):63‐6. ">Chen 2010</a>). Recently, the practice of TCM has significantly permeated a broad cross‐section of western communities (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0081" title="ZhuXS , CarltonAL , BensoussanA . Development in and challenge for traditional Chinese medicine in Australia. Journal of Alternative and Complementary Medicine2009;15(6):685‐8. ">Zhu 2009</a>). </p> <p>The forms of CHM preparations are varied; from traditional raw herbs made into a decoction, pills, liniments, plasters and ointments to concentrated powder and liquid extracts prepared by modern pharmaceutical procedures. The routes of administration also differ, either oral, topical, intravenous or injections into specific acupuncture points. Practitioners may choose to select a single herb or a complex formula consisting of several herbal ingredients. </p> <p>A formula may be used un‐tailored to individual needs and remain unchanged throughout the whole period of clinical intervention; this is known as the standard approach. Conversely, an individualised approach requires prescription of different formulae customised specifically for different individuals or modification of a basic formula during different stages of clinical intervention to respond to clinical changes if present. This is one of the underpinning theoretical constructs of TCM and a number of complementary therapies. </p> <p>TCM operates under a different theoretical paradigm to the dominant paradigm of Western biomedical science (<a href="./references#CD009023-bbs2-0081" title="ZhuXS , CarltonAL , BensoussanA . Development in and challenge for traditional Chinese medicine in Australia. Journal of Alternative and Complementary Medicine2009;15(6):685‐8. ">Zhu 2009</a>). In the case of menopausal symptoms, biomedical science has viewed menopause as the presence of organic conditions (the deficiency of ovaries due to ageing process or various medical interventions), with illness manifesting as changes in structure (e.g. dryness and thinning of skin and vaginal wall, and osteoporosis) and function of the body (such as hot flushes, poor memory, mood swings), observed at the anatomical and physiological levels, and increasingly reliant on laboratory findings for detection (i.e. increased follicle stimulating hormone (FSH) levels, decreased oestrogen and progestogen levels). </p> <p>In comparison, TCM regards illness as a syndrome or pattern (Zheng), manifesting as a disparate but mutually related set of signs and symptoms occurring throughout the whole body, and may arise from disharmony of the body (<a href="./references#CD009023-bbs2-0039" title="DengTT , GuoZQ . Diagnosis in Traditional Chinese Medicine: Textbook for national TCM tertiary education. Shanghai Science and Technology Press: Shanghai, 1983. ">Deng 1983</a>). The syndromes or diagnostic categories of TCM describe clinical patterns of both objective signs and subjective symptoms. Although the term 'menopause' does not appear in historical TCM literature, the clinical manifestations were recognised and considered to be related to hypo‐functions of the kidney. Contemporary Chinese medicine gynaecological textbooks such as <i>Gynaecology in TCM</i> (<i>Zhong Yi Fu Ke Xue</i> ) (<a href="./references#CD009023-bbs2-0056" title="LuoYK . Gynaecology in Traditional Chinese Medicine: Textbooks for National TCM Tertiary Education. Shanghai: Shanghai Science and Technology Press, 1986. ">Luo 1986</a>) also continue to attribute menopause to kidney function: that is, around the cessation of menstruation, the Kidney Qi gradually declines. The fundamental theories and approaches of TCM, reflecting upon the practice of CHM, determine contemporary scientific research and clinical practice in managing menopausal symptoms. </p> <p>Another key requirement of traditional treatment with CHM is that the treatment has to be tailored to the individual at the outset as well as modified at different stages of the patient's recovery or illness, since the clinical patterns may change during different stages. Hence, a second and distinct diagnostic process is required, as illness labelling (and therefore the treatment process) differs from conventional medical approaches (<a href="./references#CD009023-bbs2-0081" title="ZhuXS , CarltonAL , BensoussanA . Development in and challenge for traditional Chinese medicine in Australia. Journal of Alternative and Complementary Medicine2009;15(6):685‐8. ">Zhu 2009</a>). For example, a menopausal woman at onset of transition, a diagnostic pattern “Deficiency of Kidney Yin Resulting in Empty Heat” may be made in accordance with her clinical manifestations, whilst a pattern of “Deficiency of Kidney Yin and Kidney Yang” may be labelled later on when the postmenopausal stage is attained. </p> <p>These fundamental theories and approaches of TCM, reflecting on the practice of CHM, determines contemporary scientific research in the field of menopausal symptoms. Therefore, it was our intention to rigorously follow the scientific approaches whilst to fully respect the traditional philosophies and practice of Chinese medicine while conducting this systematic review. </p> </section> <section id="CD009023-sec-0026"> <h3 class="title" id="CD009023-sec-0026">How the intervention might work</h3> <p>Chinese herbal medicine is currently used in public hospitals in China for the treatment of menopause. In the last few decades, much research has investigated the efficacy, possible risks, and adverse effects of CHM for the management of menopausal symptoms. A review of the literature of 485 clinical studies (<a href="./references#CD009023-bbs2-0055" title="LiuYF , XiaoCZ , WangTF , ZhangLH , DingK J . Analysis of contemporary literature on the characteristics of Chinese herbal medicine in use, clinical manifestations and distribution of clinical patterns of menopausal syndromes. Bei Jing Zhong Yi Yao Da Xue Xue Bao [Journal of Beijing University of Traditional Chinese Medicine]2008;31(2):125‐30. ">Liu 2008</a>) in 2008 reported that 185 herbs were used to treat menopausal symptoms. Dang Gui (<i>Radix Angelicae sinensis</i>), a commonly used Chinese herb, was most frequently cited. This herb has traditionally been used to treat dysmenorrhoea, irregular menstruation and as a supportive herb for menopausal complaints (<a href="./references#CD009023-bbs2-0042" title="GellerS , StudeeL . Contemporary alternatives to plant estrogens for menopause. Maturitas2006;55(Supp1):3‐13. ">Geller 2006</a>; <a href="./references#CD009023-bbs2-0056" title="LuoYK . Gynaecology in Traditional Chinese Medicine: Textbooks for National TCM Tertiary Education. Shanghai: Shanghai Science and Technology Press, 1986. ">Luo 1986</a>). Dang Gui is reported to act by enhancing oestrogen production (<a href="./references#CD009023-bbs2-0029" title="AmatoP , ChristopheS , MellonP . Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause2002;9:145‐50. ">Amato 2002</a>).  Ren Shen (<i>Radix Panax ginseng),</i> another commonly used herb (<a href="./references#CD009023-bbs2-0052" title="KronenbergF , Fugh‐BermanA . Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Annals of Internal Medicine2002;137:805‐13. ">Kronenberg 2002</a>), has also been reported in several publications (<a href="./references#CD009023-bbs2-0066" title="OsoskiAL , KennellyEJ . Phytoestrogens: a review of the present state of research. Phytotherapy Research2003;17(8):845‐69. ">Ososki 2003</a>) to have oestrogen‐like effects on vaginal mucosa. Its extract has also been found to compete with estradiol (E<sub>2</sub>) for oestrogen‐ and progesterone‐binding sites in human myometrial cytosol (<a href="./references#CD009023-bbs2-0070" title="PunnonenRH . Oestrogen‐like effect of ginseng. British Medical Journal1980;281(6248):1110. ">Punnonen 1980</a>). This may be due to triterpene saponin, which is a subtype of isoflavone (a type of phyto‐oestrogen) (<a href="./references#CD009023-bbs2-0058" title="McBaneS . Easing vasomotor symptoms: besides HRT, what works?. JAAPA2008;21:26‐32. ">McBane 2008</a>). </p> <p>Recommendations for treating menopausal symptoms in the TCM literature are dominated by formulations which usually contain about a dozen herbs with different functions within the TCM framework. The most commonly selected herbal formula is Liu Wei Di Huang Wan, which has been used for more than one thousand years. It is also the most widely used CHM formula for the tonification of the Kidney Yin, as a basic formula for treatment in either pattern of deficiency of Kidney Yin or Kidney Yang (<a href="./references#CD009023-bbs2-0072" title="ScheidV . Traditional Chinese medicine‐what are we investigating? The case of menopause. Complementary Therapies in Medicine2007;15:54‐68. ">Scheid 2007</a>). Traditional applications listed in the Chinese Pharmacopoeia include hot flushes, night sweating, dizziness, tinnitus, weakness and soreness of limbs and lower back, and fertility dysfunctions (<a href="./references#CD009023-bbs2-0065" title="Nanjing University of Traditional Chinese Medicine. Chinese Materia Medica Pharmacopoeia. Shanghai Scientific and Technology Press, 2006. ">NJUTCM 2006</a>). </p> <p>In Liu’s review (<a href="./references#CD009023-bbs2-0055" title="LiuYF , XiaoCZ , WangTF , ZhangLH , DingK J . Analysis of contemporary literature on the characteristics of Chinese herbal medicine in use, clinical manifestations and distribution of clinical patterns of menopausal syndromes. Bei Jing Zhong Yi Yao Da Xue Xue Bao [Journal of Beijing University of Traditional Chinese Medicine]2008;31(2):125‐30. ">Liu 2008</a>), the Liu Wei Di Huang Wan formula was the most frequently cited amongst the 73 classic formulae reported in 485 studies. A randomised controlled trial (RCT) conducted by a Dutch research team (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>) used Zhi Bai Di Huang Wan (a variation of Liu Wei Di Huang Wan) versus hormone therapy (HT) and placebo to treat menopausal symptoms. The authors concluded that the formula could produce a reduction in frequency of vasomotor symptoms and that overall quality of life was also improved. However, no oestrogen was detected in the herbal formula and the mechanism of the formulation remained uncertain.     </p> </section> <section id="CD009023-sec-0027"> <h3 class="title" id="CD009023-sec-0027">Why it is important to do this review</h3> <p>Many questions about menopausal transition and its symptoms have not yet been adequately answered (<a href="./references#CD009023-bbs2-0062" title="NelsonH . Menopause. Lancet2008;371:60‐70. ">Nelson 2008</a>). Hormone therapy (HT, oestrogen alone or combined oestrogen with progestogen) is widely used to treat menopausal symptoms (<a href="./references#CD009023-bbs2-0057" title="MarjoribanksJ , FarquharC , RobertsH , LethabyA . Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews2012, Issue 7. [DOI: 10.1002/14651858.CD004143] ">Marjoribanks 2012</a>). However, there are considerable concerns regarding the adverse effects associated with conventional therapies, especially with long‐term use. The major concern is the adverse effects resulting in an increased risk of cardiovascular disease and breast cancer as reported in the Women’s Health Initiative study (<a href="./references#CD009023-bbs2-0071" title="RossouwJE , AndersonGL , PrenticeRL , LaCroixAZ , KooperbergC , StefanickML , et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomised controlled trial. JAMA2002;288(3):321‐33. ">Rossouw 2002</a>), as well as other studies (<a href="./references#CD009023-bbs2-0038" title="ColditzGA . Estrogen, oestrogen plus progestogen therapy, and risk of breast cancer. Clinical Cancer Research2005;11(2 Pt 2):909‐17. ">Colditz 2005</a>; <a href="./references#CD009023-bbs2-0068" title="PerssonI . Estrogens in the causation of breast, endometrial and ovarian cancers ‐ evidence and hypotheses from epodemiological findings. Journal of Steroid Biochemistry and Molecular Biology2000;74(5):357‐64. ">Persson 2000</a>; <a href="./references#CD009023-bbs2-0075" title="StörkS , van derShouwYT , GrobbeeD E , BotsML . Estrogen, inflammation and cardiovascular risk in women: a critical appraisal. Trends in Endocrinology and Metabolism2004;15(2):66‐72. ">Störk 2004</a>). As outlined in several Cochrane reviews, HT has been associated with an increased incidence of venous thromboembolic events, pulmonary embolus, stroke (<a href="./references#CD009023-bbs2-0033" title="BoardmanHMP , HartleyL , EisingaA , MainC , Roquéi Figuls M , Bonfill CospX , et al. Hormone therapy for preventing cardiovascular disease in post‐menopausal women. Cochrane Database of Systematic Reviews2015, Issue 3. [DOI: 10.1002/14651858.CD002229.pub4] ">Boardman 2015</a>), and gallbladder disease (<a href="./references#CD009023-bbs2-0057" title="MarjoribanksJ , FarquharC , RobertsH , LethabyA . Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews2012, Issue 7. [DOI: 10.1002/14651858.CD004143] ">Marjoribanks 2012</a>). The publication of these results and lack of confidence in pharmacological interventions have resulted in a reduction in the use of HT and an increase in complementary and alternative therapies which may include CHM (<a href="./references#CD009023-bbs2-0031" title="BairYA , GoldEB , ZhangG , RasorN , UttsJ , UpchurchD , et al. Use of complementary and alternative medicine during the menopause transition: longitudinal results from the Study of Women's Health Across the Nation [Bair YA1, Gold EB, Zhang G, Rasor N, Utts J, Upchurch DM, Chyu L, Greendale GA, Sternfeld B, Adler SR.Author information]. Menopause2008;15(1):32‐43. ">Bair 2008</a>; <a href="./references#CD009023-bbs2-0041" title="DodinS , BlanchetC , MarcI , ErnstE , WuT , VaillancourtC , PaquetteJ , MaunsellE . Acupuncture for menopausal hot flushes. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD007410] ">Dodin 2013</a>; <a href="./references#CD009023-bbs2-0042" title="GellerS , StudeeL . Contemporary alternatives to plant estrogens for menopause. Maturitas2006;55(Supp1):3‐13. ">Geller 2006</a>; <a href="./references#CD009023-bbs2-0054" title="LeachM J , MooreV . Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD007244] ">Leach 2012</a>).   </p> <p>Public interest in the use of CHM, as one of the most popular alternatives, for the improvement of menopausal symptoms is likely to increase. Although CHM is generally safe when used properly by qualified practitioners, many herbs and formulae have contraindications, and some can be toxic. Most importantly, the effectiveness and safety of long‐term use of CHM to treat menopausal symptoms is yet to be well developed within the scientific research framework. </p> <p>Given that the evidence of the safety and effectiveness of Chinese herbs for the treatment of menopausal symptoms is important, there is an urgent need for a systematic review of the available literature so that the unique needs of menopausal women can be addressed and quality of life improved. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009023-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009023-sec-0028"></div> <p>To evaluate the effectiveness and safety of Chinese herbal medicine (CHM) in the treatment of menopausal symptoms. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009023-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009023-sec-0029"></div> <section id="CD009023-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009023-sec-0031"> <h4 class="title">Types of studies</h4> <p>Only randomised controlled trials (RCTs) considering the effectiveness of CHM in menopause were eligible for inclusion. The status of RCTs was verified and confirmed through contacting the authors of primary studies. </p> <p>We planned to include cross‐over trials in the review, providing data from the first phase of the trial prior to the cross‐over phase were available, however no cross‐over trials were identified. </p> </section> <section id="CD009023-sec-0032"> <h4 class="title">Types of participants</h4> <p>Participants were limited to women 18 years of age or older with either spontaneous menopause or induced menopause through surgery or chemotherapy and/or radiotherapy who were experiencing climacteric symptoms.  </p> <p>All women, regardless of any prior or existing morbidity (e.g. cardiovascular disease, fracture, and osteoporosis). </p> </section> <section id="CD009023-sec-0033"> <h4 class="title">Types of interventions</h4> <p>The interventions included, but were not limited to, the following.</p> <p> <ul id="CD009023-list-0001"> <li> <p>Any CHM versus placebo for menopausal symptoms (this included similar variations of the comparisons, for example one formula with different doses). </p> </li> </ul> <ul id="CD009023-list-0002"> <li> <p>Any CHM versus no treatment for menopausal symptoms.</p> </li> </ul> <ul id="CD009023-list-0003"> <li> <p>Any CHM versus conventional therapy (e.g. HT) for menopausal symptoms (CHM compared with HT and other types of medication separately; similar variations of the comparisons were also included)<i>.</i> </p> </li> </ul> <ul id="CD009023-list-0004"> <li> <p>One type of CHM (e.g. oral administration) versus another type of CHM (e.g. topical use) for menopausal symptoms. </p> </li> </ul> <ul id="CD009023-list-0005"> <li> <p>Any CHM versus acupuncture for menopausal symptoms.</p> </li> </ul> </p> <p>Note:</p> <p> <ul id="CD009023-list-0006"> <li> <p>Detailed interventions included, but were not limited to, single Chinese herb and Chinese herbal formulae such as fixed/standardised formula and tailored formula. </p> </li> </ul> <ul id="CD009023-list-0007"> <li> <p>The route of administration of interventions included, but was not limited to, oral and external use. However, intravenous injection was excluded. </p> </li> </ul> <ul id="CD009023-list-0008"> <li> <p>The forms of administration included, but were not limited to, herbal decoctions, herbal extract including powders, liquid, pills/tablets/capsules, and plasters. </p> </li> </ul> <ul id="CD009023-list-0009"> <li> <p>Co‐interventions included HT, acupuncture or other traditional Chinese medicine (TCM) therapies. </p> </li> </ul> </p> </section> <section id="CD009023-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD009023-sec-0035"> <h5 class="title">Primary outcomes</h5> <p><b>1. Improvement in frequency or severity of vasomotor symptoms</b> (i.e. hot flushes, night sweats); evaluated either subjectively by participants, usually in daily diaries, or by any validated objective scoring system such as the Kupperman Index (<a href="./references#CD009023-bbs2-0053" title="KuppermanHS , WetchlerBB , BlattMH . Contemporary therapy of the menopausal syndrome. JAMA1959;171:1627‐37. ">Kupperman 1959</a>). </p> <p><b>Methods used for evaluation</b> </p> <p><b>A diary</b> may be used to capture one or more of these three types of symptoms, hot flushes, night sweats or combination of hot flushes with night sweats. Either frequency or intensity of these symptoms may be measured. For frequency, the daily number of episodes is recorded as one point. As for severity, the total number of hot flush points is calculated by assigning a number to the severity of the hot flush (mild = I, moderate = 2, severe = 3, very severe = 4), and multiplied by the daily number of hot flushes experienced at that severity level. The resulting points may be summed to give a total daily score, and each daily score is averaged over 14 days, before consultation at baseline, after treatment, and at follow‐up (<a href="./references#CD009023-bbs2-0074" title="SloanJA , LoprinziCL , NovotnyPJ , BartonDL , LavasseurBI , WindschitlH . Methodologic lessons learned from hot flash studies. Journal of Clinical Oncology2001;19(23):4280‐90. ">Sloan 2001</a>). </p> <p><b>Kupperman Index</b> (KI), also called Kupperman Index Score (KIS), is a questionnaire containing 11 menopausal‐related symptoms. Each symptom is rated from 0 ‐ 3 according to severity and symptoms (where 0 = no symptoms, and 3 = most severe), weighted, and the total sum is calculated with a possible maximum score of 51; higher scores indicate more severe symptoms. </p> </section> <section id="CD009023-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p><b>1. Improvement in other menopausal symptoms</b> derived from overall numerical results by using different measurements e.g. Kupperman Index (KI) (<a href="./references#CD009023-bbs2-0053" title="KuppermanHS , WetchlerBB , BlattMH . Contemporary therapy of the menopausal syndrome. JAMA1959;171:1627‐37. ">Kupperman 1959</a>); Menopause‐Specific Quality of Life Questionnaire (MENQOL) (<a href="./references#CD009023-bbs2-0050" title="HilditchJR , LewisJ , PeterA , vanMarisB , RossA , FranssenE , et al. A menopause‐specific quality of life questionnaire: development and psychometric properties. Maturitas1996;24(3):161‐75. ">Hilditch 1996</a>); Greene Climateric Scale (GCS) (<a href="./references#CD009023-bbs2-0045" title="GreeneJG . A factor analytic study of climacteric symptoms. Journal of Psychosomatic Research1976;20(5):425‐30. ">Greene 1976</a>); Women's Health Questionnaire (WHQ) (<a href="./references#CD009023-bbs2-0051" title="HunterMS . The women's health questionnaire: a measure of mid‐aged women's perceptions of their emotional and physical health. Psychology &amp; Health1992;7(1):45‐54. ">Hunter 1992</a>); Menopause Rating Scale (MRS) (<a href="./references#CD009023-bbs2-0047" title="HauserGA , HuberIC , KellerPJ , LauritzenC , SchneiderHP . Evaluation of climacteric symptoms (Menopause Rating Scale) [Article in German]. Zentralblatt für Gynäkologie1994;116(1):16‐23. ">Hauser 1994</a>; <a href="./references#CD009023-bbs2-0048" title="HeinemannLAJ , PotthoffP , SchneiderHPG . International versions of the Menopause Rating Scale (MRS). Health and Quality of Life Outcomes2003;1:28. ">Heinemann 2003</a>; <a href="./references#CD009023-bbs2-0069" title="PotthoffP , HeinemannLA , SchneiderHP , RosemeierHP , HauserGA . The Menopause Rating Scale (MRS II): methodological standardization in the German population [Article in German]. Zentralblatt für Gynäkologie2000;122(5):280‐6. ">Potthoff 2000</a>); and Hot Flash Related Daily Interference Scale (HFRDI) (<a href="./references#CD009023-bbs2-0034" title="CarpenterJS . The Hot Flash Related Daily Interference Scale; a tool for assessing the impact of hot flashes on quality of life following breast cancer. Journal of Pain Symptom Management2001;22(6):979‐9. ">Carpenter 2001</a>). Chinese studies tended to use different measurements; measuring a successful rate for menopausal symptoms (<a href="./references#CD009023-bbs2-0061" title="Ministry of Health of the People's Republic of China. Clinical Standards for Diagnostic Evidence and Treatment Outcome Evaluation. Beijing: People's Health Publishing House, 1995. ">Ministry of Health of PRC 1995</a>). </p> <p><b>Rating scales</b> </p> <p><b>The Menopause‐Specific Quality of Life Questionnaire</b> (MENQOL) is interchangable with Menopause Specific Quality of Life (MSQOL). It is a condition‐specific validated measure of Health‐Related Quality of Life (HRQoL). It is a 29‐item questionnaire covering domains of physical, emotional and social aspects which defines if a therapeutic intervention affects an individual’s quality of life specific to menopause symptoms. Participants are asked about their symptoms in the previous month and rate problems on a seven‐point Likert Scale (0 = no bother and 6 = extremely bothered). Systematic scoring for each domain is identical. Each domain is scored by averaging the manipulated values. </p> <p>Means are computed for each subscale by dividing the sum of the domain’s items by the number of items within that domain. Non‐endorsement of an item is scored a '1' and endorsement a '2' plus the number of the particular rating, so that the possible score on any item ranges from 0 to 8. </p> <p><b>The Greene Climateric Scale</b> (GCS) is a 21‐item questionnaire assessing menopausal symptoms in three domains including psychological, physical and vasomotor with four ratings (0 = not at all, 1 = a little, 2 = quite a bit, and 3 = extremely). Lower points indicate better health‐related quality of life rated from 0 to 63. </p> <p><b>The Women's Health Questionnaire</b> (WHQ) is a 37‐item questionnaire evaluating nine domains including physical and emotional areas with four‐point scale, with more points indicating more normal disturbance, and less points indicating less normal disturbance. </p> <p><b>The Menopause Rating Scale</b> (MRS) is an 11‐item questionnaire covering three dimensions, psychological, somatic and urogenital, with participants marking each question according to severity of symptoms on a scale of 0 to 4. Lower points indicate a better quality of life. </p> <p><b>The Hot Flash Related Daily Interference Scale (</b>HFRDI) is used to measure the impact of hot flushes on overall quality of life (item 10) as well as on nine specific activities (items 1 to 9: work, social activities, leisure activities, sleep, mood, concentration, relations with others, sexuality, enjoyment of life). It consists of a series of 0‐ to‐10 point numeric rating scales. Hot flushes are rated based on how much they have interfered with each item during the previous week using a 0 (do not interfere) to 10 (completely interfere) point scale. A total score is computed by summing items. Higher scores indicate higher interference resulted from hot flushes. </p> <p><b>Improvement in menopausal symptoms</b>: this method was reported in some of the included Chinese studies. According to the authority standards, outcomes of treatment are generally defined as 'curing' (the major menopausal symptoms have completely disappeared), 'improving' (the symptoms have improved in severity or/and frequency), and 'not responding' (there has been no improvement at all). A successful/unsuccessful rate is usually calculated as the total number of women being cured, or improved, or with no improvement divided by the total number of participants expressed as a percentage. Some studies also considered Chinese medicine diagnostic patterns, which is a unique approach in the practice of TCM when successful or unsuccessful rate is applied. The data (rate) were therefore treated as dichotomous data. </p> <p><b>2.  Adverse effects</b>, measured as a self‐report of incidence and/or liver and renal function tests. </p> <p><b>3. Quality of life measured by a validated scale</b> (e.g. SF‐36, MENQOL (<a href="./references#CD009023-bbs2-0050" title="HilditchJR , LewisJ , PeterA , vanMarisB , RossA , FranssenE , et al. A menopause‐specific quality of life questionnaire: development and psychometric properties. Maturitas1996;24(3):161‐75. ">Hilditch 1996</a>). </p> <p><b>4.  Satisfaction of treatment</b> as reported by women, measured as the proportion of women who reported improvements or satisfaction, or both, with their treatment. </p> <p>The primary outcome in our protocol was defined as 'improvement in frequency or intensity of vasomotor symptoms (i.e. hot flushes and night sweats) evaluated subjectively by participants, usually in daily diaries or by any validated objective scoring system such as Kupperman Index; however it was noted that the definition failed to provide wider scopes to the research topic, for example, when either hot flushes or night sweats were measured based on overall scores rather than frequency and intensity, and in a few studies, vasomotor symptoms were also measured based on overall scores without distinguishing hot flushes and night sweats. Hence, more relevant outcomes in the review were considered and evaluated accordingly with only KI and MENQOL, which are the most commonly used measurements. </p> <p>We also modified the secondary outcomes; only overall scores were analysed, subsets of questionnaires were not included. </p> <p>The relevant outcomes of each comparison are reported as below.</p> <p>The primary outcome was modified to changes of vasomotor symptoms including:</p> <p> <ul id="CD009023-list-0010"> <li> <p>changes in frequency of hot flushes/night sweats;</p> </li> <li> <p>changes in intensity of hot flushes/night sweats;</p> </li> <li> <p>changes in overall scores of hot flushes/night sweats;</p> </li> <li> <p>changes in overall scores of vasomotor symptoms.</p> </li> </ul> </p> <p>The secondary outcomes are reported accordingly as below:</p> <p> <ul id="CD009023-list-0011"> <li> <p>menopausal symptoms;</p> </li> <li> <p>adverse effects;</p> </li> <li> <p>quality of life (QoL);</p> </li> <li> <p>satisfaction of treatment.</p> </li> </ul> </p> <p>All these changes are notified in the <a href="#CD009023-sec-0143">Differences between protocol and review</a>. </p> </section> </section> </section> <section id="CD009023-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009023-sec-0038"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Gynaecology and Fertility Group's search strategy was adopted in consultation with the Trial Search Co‐ordinator. Reports which described (or might have described) RCTs of CHM in the treatment of menopause were obtained using the following search strategy. </p> <p> <ul id="CD009023-list-0012"> <li> <p>The Gynaecology and Fertility Group's Specialised Register of Controlled Trials was searched for any trials within the scope in the title, abstract or keyword sections. </p> </li> <li> <p>The following electronic databases were searched from their inception to March 2015:</p> </li> </ul> <ul class="plain" id="CD009023-list-0013"> <li> <ul id="CD009023-list-0014"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL 2015, Issue 3), MEDLINE, Embase, CINAHL, AMED, and PsycINFO. </p> </li> </ul> </li> </ul> </p> <p>The MEDLINE search was combined with the Cochrane highly sensitive search strategy for identifying randomised trials, which appeared in the searching chapter of The <i>Cochrane Handbook of Systematic Reviews of Interventions</i> (<a href="./references#CD009023-bbs2-0049" title="HigginsJ P T , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration: www.cochrane‐handbook.org.2011. ">Higgins 2011</a>). </p> <p>The Embase search was combined with trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (http://www.sign.ac.uk/methodology/filters.html#random) </p> <p>Other electronic sources of trials included were:‐</p> <p>Trial registers for ongoing and registered trials ‐ 'Current Controlled Trials' (http://www.controlled‐trials.com/), 'ClinicalTrials.gov' a service of the US National Institutes of Health (http://clinicaltrials.gov/ct2/home) and 'The World Health Organization International Trials Registry Platform search portal' (http://www.who.int/trialsearch/Default.aspx) </p> <p>Citation indexes (http://scientific.thomson.com/products/sci/)</p> <p>Conference abstracts in the Web of Knowledge (http://wokinfo.com/)</p> <p>LILACS database, as a source of trials from the Portuguese and Spanish speaking world (http://bases.bireme.br/cgibin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis&amp;base=LILACS&amp;lang=i&amp;form=F) </p> <p>PubMed (http://www.ncbi.nlm.nih.gov/pubmed/), the random control filter for PubMed was taken from the chapter on searching in the <i>Cochrane Handbook of Systematic Reviews of Interventions</i> </p> <p>OpenSIGLE database (http://opensigle.inist.fr/) and Google for grey literature.</p> <p> <ul id="CD009023-list-0015"> <li> <p> We searched one of the commonly used electronic Chinese databases namely The China National Knowledge Infrastructure (CNKI, 1999 to 2015) as recommended by the Gynaecology and Fertility Group.   </p> </li> </ul> </p> <p>See appendices for the specific search string used <a href="./appendices#CD009023-sec-0129">Appendix 1</a>; <a href="./appendices#CD009023-sec-0130">Appendix 2</a>; <a href="./appendices#CD009023-sec-0131">Appendix 3</a>; <a href="./appendices#CD009023-sec-0132">Appendix 4</a>; <a href="./appendices#CD009023-sec-0133">Appendix 5</a>; <a href="./appendices#CD009023-sec-0134">Appendix 6</a>; <a href="./appendices#CD009023-sec-0135">Appendix 7</a>; <a href="./appendices#CD009023-sec-0136">Appendix 8</a>. </p> </section> <section id="CD009023-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We handsearched the reference lists of articles retrieved by the search and contacted experts in the field and the manufacturers of CHM in order to obtain additional relevant data. </p> <p>We handsearched any relevant journals and conference abstracts that were not covered in the Gynaecology and Fertility Group's register, in liaison with the Trial Search Co‐ordinator. </p> </section> </section> <section id="CD009023-sec-0040"> <h3 class="title" id="CD009023-sec-0040">Data collection and analysis</h3> <p>Data collection and analysis were conducted in accordance with the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009023-bbs2-0049" title="HigginsJ P T , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration: www.cochrane‐handbook.org.2011. ">Higgins 2011</a>). </p> <section id="CD009023-sec-0041"> <h4 class="title">Selection of studies</h4> <p>The study selection was undertaken by two review authors (XZ and ZL). The titles and abstracts of articles found by the search were screened by XZ, who discarded studies that were clearly ineligible but aimed to be inclusive rather than risk losing relevant studies. XZ obtained copies of the full‐text articles and made copies for ZL in which details of the authors and institutions had been struck out and the results section removed. Both review authors independently assessed whether the studies met the inclusion criteria, and disagreements were resolved by discussion. Further information was sought from the authors where papers contain insufficient information to enable assessment for eligibility. </p> </section> <section id="CD009023-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>All assessments on the quality of trials and data extraction were performed independently by the two review authors (XZ and ZL). Data were extracted onto a pre‐developed data extraction sheet to assess study characteristics including the location of the study, methods of the study (as per quality assessment checklist), the participants (age range, eligibility criteria), the nature of the interventions, and data relating to the outcomes specified above. Any discrepancies were resolved by a third review author (YL). </p> <p>Additional information on the trial methodology or actual original trial data were sought from the principal author of those trials that appeared to meet the eligibility criteria, when aspects of methodology were unclear, or where the data were in a form unsuitable for meta‐analysis. </p> </section> <section id="CD009023-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The included studies were assessed for risk of bias using the Cochrane 'Risk of bias' assessment tool to assess the following domains: sequence generation; allocation concealment; blinding of participants, providers and outcome assessors; completeness of outcome data; selective outcome reporting; and other potential sources of bias. Two review authors (XZ and ZL) assessed these six domains, with any disagreements resolved by consensus or by discussion with the third review author (YL). All judgments were fully described and presented in the ‘Risk of bias' tables in accordance with the standards as below. </p> <section id="CD009023-sec-0044"> <h5 class="title">Sequence generation</h5> <p> <ul id="CD009023-list-0016"> <li> <p>Low risk of bias: the method used was considered either adequate (e.g. computer‐generated random numbers, table of random numbers) or unlikely to introduce confounding. </p> </li> <li> <p>Uncertain risk of bias: there was insufficient information to assess whether the method used was likely to introduce confounding. </p> </li> </ul> </p> </section> <section id="CD009023-sec-0045"> <h5 class="title">Allocation concealment</h5> <p> <ul id="CD009023-list-0017"> <li> <p>Low risk of bias: the method used (e.g. central allocation) was unlikely to induce bias on the final observed effect. </p> </li> <li> <p>Uncertain risk of bias: there was insufficient information to assess whether the method used was likely to induce bias on the estimate of effect. </p> </li> <li> <p>High risk of bias: the method used (e.g. open random allocation schedule) was likely to induce bias on the final observed effect. </p> </li> </ul> </p> </section> <section id="CD009023-sec-0046"> <h5 class="title">Blinding</h5> <p> <ul id="CD009023-list-0018"> <li> <p>Low risk of bias: the trial was described as blinded, the parties that were blinded, and the method of blinding was described, so that knowledge of allocation was adequately prevented during the trial. </p> </li> <li> <p>Uncertain risk of bias: the trial was described as blinded, but the method of blinding was not described, so that knowledge of allocation was possible during the trial. </p> </li> <li> <p>High risk of bias, the trial was not blinded, so that the allocation was known during the trial. </p> </li> </ul> </p> </section> <section id="CD009023-sec-0047"> <h5 class="title">Incomplete outcome data</h5> <p> <ul id="CD009023-list-0019"> <li> <p>Low risk of bias: the numbers and reasons for dropouts and withdrawals in all intervention groups were described, or if it was specified that there were no dropouts or withdrawals. </p> </li> <li> <p>Uncertain risk of bias: the report gave the impression that there had been no dropouts or withdrawals, but this was not specifically stated. </p> </li> <li> <p>High risk of bias: the number or reasons for dropouts and withdrawals were not described or dropout rates were high. </p> </li> </ul> </p> </section> <section id="CD009023-sec-0048"> <h5 class="title">Selective outcome reporting</h5> <p> <ul id="CD009023-list-0020"> <li> <p>Low risk of bias: predefined, or clinically relevant and reasonably expected outcomes were reported. </p> </li> <li> <p>Uncertain risk of bias: not all predefined, or clinically relevant and reasonably expected outcomes were reported, or were not reported fully, or it was unclear whether data on these outcomes were recorded or not. </p> </li> <li> <p>High risk of bias: one or more clinically relevant and reasonably expected outcomes were not reported; data on these outcomes were likely to have been recorded. </p> </li> </ul> </p> </section> <section id="CD009023-sec-0049"> <h5 class="title">Other bias</h5> <p>In addition to the above‐mentioned biases, industry, academic, or other bias that could be detected were also considered. </p> <p> <ul id="CD009023-list-0021"> <li> <p>Low risk of other bias: the trial appeared to be free of any risk of bias.</p> </li> <li> <p>Uncertain risk of bias: the trial may or may not have been free of any risk of bias.</p> </li> <li> <p>High risk of other bias: there were other factors in the trial that could lead a risk of bias; for example, unequal groups as baseline. </p> </li> </ul> </p> </section> </section> <section id="CD009023-sec-0050"> <h4 class="title">Measures of treatment effect</h4> <p>Statistical analyses were performed in accordance with the guidelines described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009023-bbs2-0049" title="HigginsJ P T , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration: www.cochrane‐handbook.org.2011. ">Higgins 2011</a>). </p> <p>For continuous outcome data, results from each study were expressed as a difference in means with 95% confidence intervals and combined for meta‐analysis using the mean difference (MD) if all studies reported exactly the same outcomes. Where different scales were used to report the same outcomes (e.g. hot flushes); we planned to use the standardised mean difference (SMD). </p> <p>Ordinal data (e.g. quality of life (QoL) scores) were treated as continuous data and 95% confidence intervals were presented for all outcomes.<br/> <br/> A random‐effects approach was used to calculate summary effect measures, as a priori it was expected that analyses would have heterogeneous results. </p> <p>For binary outcomes, results for each study were expressed as risk ratios (RR) with 95% confidence intervals and combined for meta‐analysis using the Peto method. </p> <p>Confidence intervals (95%) were presented for all outcomes and comparisons.</p> </section> <section id="CD009023-sec-0051"> <h4 class="title">Unit of analysis issues</h4> <p>Dichotomous outcomes were analysed as per woman randomised (e.g. number of women with an adverse effect/total number of women randomised). When data were presented in continuous form, the data were treated so participants from individual trials were included only once in each comparison. </p> </section> <section id="CD009023-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the primary authors of studies by email to obtain any missing participant data and we recorded the rate of contact. When we were unable to obtain missing data, analyses were based on populations in which outcomes were reported. Discrepancies between the number of participants enrolled and number for whom outcomes were reported were noted in the <a href="./references#CD009023-sec-0145" title="">Characteristics of included studies</a> table. Data were analysed on an intention‐to‐treat basis when available. </p> </section> <section id="CD009023-sec-0053"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered heterogeneity when clinical and methodological characteristics of included studies were suitable for a meta‐analysis. Statistical analyses were performed in accordance with the guidelines for statistical analysis described in <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009023-bbs2-0049" title="HigginsJ P T , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration: www.cochrane‐handbook.org.2011. ">Higgins 2011</a>). </p> <p>Heterogeneity was identified by visual inspection of the forest plots with a standard Chi<sup>2</sup>. Heterogeneity (variation) between the results of different studies was specifically examined by using the I<sup>2</sup> statistic (a quantity that describes approximately the proportion of variation in point estimates that is due to heterogeneity rather than sampling error), which can be interpreted when I<sup>2</sup> was identified at the following ranges. </p> <p> <ul id="CD009023-list-0022"> <li> <p>0% to 40%: might not be important.</p> </li> </ul> <ul id="CD009023-list-0023"> <li> <p>30% to 60%: represents moderate heterogeneity.</p> </li> </ul> <ul id="CD009023-list-0024"> <li> <p>50% to 90%: represents substantial heterogeneity.</p> </li> </ul> <ul id="CD009023-list-0025"> <li> <p>75% to 100%: represents considerable heterogeneity (<a href="./references#CD009023-bbs2-0049" title="HigginsJ P T , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration: www.cochrane‐handbook.org.2011. ">Higgins 2011</a>). </p> </li> </ul> </p> <p>If an I<sup>2</sup> was between 50% and 85%, we used a random‐effects model for analysis. If an I<sup>2</sup> was greater than 85%, meta‐analysis was not performed. Pre‐determined subgroup analyses according to standard formulation and individualised formulation (data were not available) were preformed in order to explore the cause(s) of heterogeneity. </p> </section> <section id="CD009023-sec-0054"> <h4 class="title">Assessment of reporting biases</h4> <p>In view of the difficulty in detecting and correcting for publication bias and other reporting biases, we aimed to minimise their potential impact by ensuring a comprehensive search for eligible studies and by being alert for duplication of data. We planned to prepare a funnel plot if there were 10 or more studies in one analysis, however, too few studies were identified for a funnel plot construction. </p> </section> <section id="CD009023-sec-0055"> <h4 class="title">Data synthesis</h4> <p>The data from primary studies were combined in the following comparisons:</p> <p> <ul id="CD009023-list-0026"> <li> <p>CHM versus placebo;</p> </li> <li> <p>CHM versus active medications (including HT);</p> </li> <li> <p>CHM versus another CHM (including comparisons between different doses).</p> </li> </ul> </p> <p>No study reported on CHM versus no treatment.</p> <p>An increase or decrease in the odds of a particular outcome, which may be beneficial or detrimental, were displayed graphically in the meta‐analyses. An increase in the odds of an outcome was displayed to the right of the centre line while a decrease in the odds of an outcome was displayed to the left of the centre line. </p> <p>When meta‐analyses were conducted, either random‐effects model or fixed‐effect model might be used. When there was no significant or substantial heterogeneity (an I<sup>2</sup> less than 50%), only results from the fixed‐effect model were presented. When heterogeneity was over 85%, meta‐analysis was not performed, since the effect estimate did not reflect the 'true' value, hence a narrative, qualitative summary was provided instead. </p> <p>In the event of high clinical, methodological or statistical heterogeneity, we did not combine study results by means of meta‐analysis, but instead, summarised them in narrative form. </p> </section> <section id="CD009023-sec-0056"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>The protocol stated that where data were available, subgroup analyses would be conducted to determine the evidence of different types of Chinese herbal formulation, that is, standard formulation and individualised formulation, in order to investigate heterogeneous results. Since the data were unavailable, subgroup analysis was not undertaken. </p> </section> <section id="CD009023-sec-0057"> <h4 class="title">Sensitivity analysis</h4> <p>We undertook a sensitivity analysis for the primary outcomes to determine whether review conclusions would have differed if eligibility were restricted to studies deemed at low risk of bias. </p> <p>The following aspects of quality were considered for this sensitivity analysis: inadequate blinding, non‐comparable groups (because they had different baseline characteristics), and no intention‐to‐treat analysis. </p> <section id="CD009023-sec-0058"> <h5 class="title">Overall quality of the body of evidence: Summary of findings tables</h5> <p>We prepared two Summary of findings tables using GRADEPRO, see <a href="./full#CD009023-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD009023-tbl-0002">summary of findings Table 2</a>. These tables evaluate the overall quality of the body of evidence for the main review outcomes: vasomotor symptoms were assessed by different aspects, including frequency of hot flushes, severity of hot flushes, overall hot flushes, and overall night sweats. Vasomotor symptoms were also assessed by validated questionnaires, including the modified Kupperman Index Scale (KIS), the Menstrual‐Specific Quality of Life (MENQOL), the Green Climacteric Scale (GCS) and the Menopause Rating Scale (MRS). The GRADE criteria including study limitations (i.e. risk of bias), consistency of effect, imprecision, indirectness and publication bias were adopted. Judgements about evidence quality (high, moderate or low) were justified, documented, and incorporated into reporting of results for each outcome in relation to the primary outcome. </p> <p>Reliable synthesis was not possible in our other comparisons (CHM versus conventional therapy (fluoxetine &amp; estazol) and CHM versus another CHM) where small studies reported only one secondary outcome. Because of insufficient data we did not present a summary of findings table for these comparisons. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009023-sec-0059" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009023-sec-0059"></div> <section id="CD009023-sec-0060"> <h3 class="title">Description of studies</h3> <section id="CD009023-sec-0061"> <h4 class="title">Results of the search</h4> <p>The search retrieved 864 articles. Twenty‐eight studies were potentially eligible and we retrieved the full‐text articles. Twenty‐two studies met our inclusion criteria. Six studies were excluded. For detailed information, see study tables: <a href="./references#CD009023-sec-0145" title="">Characteristics of included studies</a> and <a href="./references#CD009023-sec-0146" title="">Characteristics of excluded studies</a>. We prepared a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) flow diagram to describe the publications found through our searches (<a href="#CD009023-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD009023-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) flow‐chart of study selection." data-id="CD009023-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) flow‐chart of study selection. </p> </div> </div> </div> </section> <section id="CD009023-sec-0062"> <h4 class="title">Included studies</h4> <p><b>Study design and setting</b> </p> <p>Twenty‐two parallel‐design randomised controlled trials (RCTs) were included in the review (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>; <a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>).<br/> All were single‐centre studies with three studies conducted in outpatient clinics in Australia (<a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>), The Netherlands (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>) and the USA (<a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>). The majority of studies, (19) were conducted in China, including two in Hong Kong (<a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>). </p> <p><b>Participants<br/></b> <br/> <br/> The studies included 2902 women with a total of 1499 participants in the intervention groups and 1403 in the control groups. Women were diagnosed with menopause by one or more of the following assessment items including gynaecological examination, serum hormone levels (follicle stimulating hormone (FSH) &gt; ranged from 4 to 40 IU/L, luteinizing hormone (LH) &gt; 12.6 IU/L, and E<sub>2</sub> &lt; ranged from 20 to 361 pg/mL), and menstrual scores. Nine out of the 22 studies also considered a specific Chinese medicine diagnostic pattern as one of the key inclusion criteria (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>). </p> <p><b>Menopause symptoms</b> </p> <p>The menopausal symptoms reported in the studies varied widely. In terms of descriptive symptoms, there were hot flushes, night sweats, combination of these two symptoms, symptoms of hot flushes and night sweats with emotional disturbance and sleep problems. The tools for measuring these symptoms also varied across the studies, for example, hot flushes might be measured alone as intensity, or frequency; or might be assessed as part of overall symptoms. </p> <p><b>Interventions and controls</b> </p> <p> <ul id="CD009023-list-0027"> <li> <p>No study compared Chinese herbal medicine (CHM) versus no treatment.</p> </li> <li> <p>8/22 studies compared CHM versus placebo (including one study that compared CHM plus placebo versus placebo). </p> </li> <li> <p>10/22 studies compared CHM versus conventional therapy, specifically hormone therapy (HT), (including one study that compared CHM plus placebo versus HT plus placebo. </p> </li> <li> <p>2/22 studies compared CHM versus conventional therapy (other than HT).</p> </li> <li> <p>2/22 studies compared CHM versus another formula of CHM.</p> </li> <li> <p>No study compared CHM versus acupuncture.</p> </li> </ul> </p> <p><i>Formulae and Ingredients</i>: There was huge variation in formulations: 21 formulae with 91 herbal ingredients were tested. However there was a tendency to use certain herbs in menopause research, for example, the following 11 herbs were identified as the most frequently tested. The list below reports how often and which herbs were used in the relevant included studies in detail. </p> <p><b>Herbs tested</b> </p> <p> <ul id="CD009023-list-0028"> <li> <p>Bai Shao Yao Radix Paeoniae Alba (eight studies) (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). </p> </li> <li> <p>Dang Gui Radix Angelicae Sinensis (seven studies) <i>(</i><a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>). </p> </li> <li> <p>Di Huang Radix Rehmanniae Preparata (seven studies) (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). </p> </li> <li> <p>Fu Ling Poria (seven studies) (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). </p> </li> <li> <p>Zhi Mu Rhizoma Anemarrhenand (six studies) (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>). </p> </li> <li> <p>Shan Yao <i>Rhizoma Dioscoreae Oppositae</i> (six studies) (<a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>). </p> </li> <li> <p>Suan Zao Ren <i>Semen Z spinosae</i> (five studies) (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>). </p> </li> <li> <p>Shan Zhu Yu/ShanYu Rou Fructus Corni (five studies) (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>). </p> </li> <li> <p>Mu Dan Pi <i>Cortex Moutan Radicis</i> (five studies) (<a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>). </p> </li> <li> <p>Yin Yang Huo <i>Herba Epimedii</i> (four studies) <i>(</i><a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>). </p> </li> <li> <p>Dan Shen <i>Radix Salviae Miltiorrhizae</i> (four studies) (<a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>). </p> </li> <li> <p>Huang Bai <i>Cortex Phellodendri</i> (three studies) (<a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>). </p> </li> </ul> </p> <p><i>Styles of formulation</i> : 20/22 studies investigated a standard formula throughout the trial period. Only one study (<a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>), looked into a few tailored formulae for women diagnosed with different traditional Chinese medicine (TCM) diagnostic patterns, but used throughout the course of the intervention without modification; one study (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>), adapted an approach with a standard formula adding limited modifications in herb compositions. Interestingly, no study assessed the use of just a single herb or a complete individualised approach (i.e. each patient is given as many different formulae as possible based on individual clinical presentation, and a formula may be changed during the course of intervention, which is the typical TCM diagnostic approach). </p> <p><i>Forms of herbs</i>: The most popular form of CHM was herbal extract in the form of granules which was used in 17/22 studies (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>); only five studies used a traditional form as a decoction (<a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>. All herbs were administered internally. </p> <p><i>Reporting involved herbs and dosages</i>: 14/22 studies reported full compositions of the herbal formulae (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>; <a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>). By contrast, eight studies did not report full ingredients used in their studies (<a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). Eleven studies mentioned the full dosages of the involved ingredients (<a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>); information on full dosages of the studied ingredients was missing in the remaining 11 studies (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). </p> <p><i>Length of intervention</i>: the lengths of trial period varied from a period of four weeks to 106 weeks, however a substantial number of the included studies (9/22) were for 12 weeks (<a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>). A period of four weeks as intervention period was used in four studies (<a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>); eight weeks in three studies (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>); only one study had a 16‐week intervention (<a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>) and one study a 106‐week intervention, which was extremely long (<a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>); two studies had a period as long as 24 weeks (<a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>) and 52 weeks (<a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). </p> <p><i>Length of lead‐in and follow‐up periods:</i> Only three studies had a lead‐in period from one week (<a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>), to two weeks (<a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>), and four weeks (<a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>). Three studies had a follow‐up with either a period of four weeks (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>),eight weeks (<a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>), or 12 weeks (<a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>). </p> <p><b>Outcomes</b> </p> <p> <ul id="CD009023-list-0029"> <li> <p>6/22 studies reported vasomotor symptoms (<a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). </p> </li> <li> <p>12/22 reported menopausal symptoms (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a><a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>). </p> </li> <li> <p>2/22 reported quality of life in general (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). </p> </li> <li> <p>16/22 reported adverse effects (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). </p> </li> <li> <p>No study reported the outcome of satisfaction of treatment.</p> </li> <li> <p>13/22 reported levels of hormone changes (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>), however these were not outcomes of interest in the review. </p> </li> </ul> </p> <p>The way of reporting the <b>primary outcome</b> in the review was slightly modified for clarity. </p> <p>Changes of vasomotor symptoms were measured by the following methods.</p> <p> <ul id="CD009023-list-0030"> <li> <p>Frequency of hot flushes/night sweats</p> </li> <li> <p>Severity of hot flushes/night sweats</p> </li> <li> <p>Overall scores of hot flushes/night sweats (frequency and severity)</p> </li> <li> <p>Overall scores of vasomotor symptoms (hot flushes and night sweats)</p> </li> </ul> </p> <p>The <b>secondary outcomes</b> were assessed according to the following order. </p> <p> <ul id="CD009023-list-0031"> <li> <p>Menopausal symptoms</p> </li> <li> <p>Adverse effects</p> </li> <li> <p>Quality of life (QoL)</p> </li> <li> <p>Satisfaction of treatment</p> </li> </ul> </p> <p>See <a href="#CD009023-sec-0143">Differences between protocol and review</a> for the modifications made and the rationale. </p> </section> <section id="CD009023-sec-0063"> <h4 class="title">Excluded studies</h4> <p>Six studies were excluded from the review, for the following reasons.</p> <p> <ul id="CD009023-list-0032"> <li> <p>One study was not true RCT</p> </li> </ul> <ul id="CD009023-list-0033"> <li> <p>One study reported with data not retrievable (when the corresponding author of this study was contacted on several occasions, it was reported that there was no original data available for any clarification, this study was therefore excluded due to concerns regarding the quality of study) </p> </li> </ul> <ul id="CD009023-list-0034"> <li> <p>Three studies reported primary outcomes that were not of interest for this review such as hypotension, eye conditions and psychological disorders </p> </li> <li> <p>One study investigated different dosages in one formula</p> </li> </ul> </p> </section> </section> <section id="CD009023-sec-0064"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD009023-sec-0065"> <h4 class="title">Allocation</h4> <p><b>Sequence generation</b> </p> <p>All 22 studies were at low risk of selection bias in relation to sequence generation, either computer‐generated randomisation or a random numbers table was used. </p> <p><b>Allocation concealment</b> </p> <p>Sixteen studies did not report how allocation concealment was carried out (<a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). Only five studies reported that allocation concealment was implemented, therefore was considered to have at low risk of selection bias (<a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>). One study did not carry out allocation concealment, resulting in a high risk of bias (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>). Detailed information is shown in <a href="#CD009023-fig-0002">Figure 2</a> and <a href="#CD009023-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD009023-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009023-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD009023-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009023-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD009023-sec-0066"> <h4 class="title">Blinding</h4> <p>In nine studies participants and personnel were blinded (<a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>), but 12/22 participants and personnel were not blinded (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>;<a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a><a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>); in the remaining study it was unclear if blinding was undertaken (<a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>). Given that more than fifty per cent of included studies did not introduce appropriate blinding methods, performance bias and detection bias existed, which partially influenced the primary outcome. However, non blinding occurred mainly in the studies in which CHM was compared against HT, and we did not consider that blinding was likely to influence findings for the objective secondary outcomes such as changes in levels of the hormones and lipids; adverse effects were also unlikely to be affected. </p> <p>Eight included studies compared CHM with placebo (<a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>); all of these studies described the use of a placebo identical to the intervention and were thus deemed to be at low risk of performance bias. </p> <p>In regards to blinding of outcome assessors, six included studies described blinding of outcome assessors, which appeared to be at low risk of detection bias (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>). However, the remaining 16 studies did not report if outcome assessors including data entry personnel and statisticians were blinded (<a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>; <a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). </p> <p>Detailed information is shown in <a href="#CD009023-fig-0002">Figure 2</a> and <a href="#CD009023-fig-0003">Figure 3</a>. </p> </section> <section id="CD009023-sec-0067"> <h4 class="title">Incomplete outcome data</h4> <p>We judged 13 studies with 1240 women randomised and analysed to be at low risk of bias (<a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). </p> <p>Eight studies with 1640 women were considered to be at high risk of attrition bias with either intention‐to‐treat (ITT) being not mentioned or not implemented (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>; <a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>). </p> <p>One study was rated as unclear (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>). </p> <p>Detailed information is shown in <a href="#CD009023-fig-0002">Figure 2</a> and <a href="#CD009023-fig-0003">Figure 3</a>. </p> </section> <section id="CD009023-sec-0068"> <h4 class="title">Selective reporting</h4> <p>All expected aspects were reported in 20/22 included studies (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>; <a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>), which we judged to be at low risk of bias. Two studies did not report expected outcomes (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>), or had no pre‐specified outcomes (<a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>) and both were deemed to be at high risk of bias. </p> <p>Detailed information is shown in <a href="#CD009023-fig-0002">Figure 2</a> and <a href="#CD009023-fig-0003">Figure 3</a>. </p> </section> <section id="CD009023-sec-0069"> <h4 class="title">Other potential sources of bias</h4> <p>We found no potential sources of within‐study bias in the 22 studies. Detailed information is shown in <a href="#CD009023-fig-0002">Figure 2</a> and <a href="#CD009023-fig-0003">Figure 3</a>. </p> </section> </section> <section id="CD009023-sec-0070"> <h3 class="title" id="CD009023-sec-0070">Effects of interventions</h3> <p>See: <a href="./full#CD009023-tbl-0001"><b>Summary of findings for the main comparison</b> Chinese herbal medicine (CHM) compared with placebo for menopausal symptoms</a>; <a href="./full#CD009023-tbl-0002"><b>Summary of findings 2</b> CHM compared with HT for menopausal symptoms</a> </p> <p>In terms of comparisons, results in this review are reported according to the following sequence. </p> <p> <ul id="CD009023-list-0035"> <li> <p>CHM versus placebo</p> </li> <li> <p>CHM versus no treatment</p> <ul id="CD009023-list-0036"> <li> <p>including CHM + placebo versus placebo</p> </li> </ul> </li> <li> <p>CHM + conventional therapy (drug as short term) versus placebo + conventional therapy (drug) </p> </li> <li> <p>CHM versus conventional therapy (HT)</p> <ul id="CD009023-list-0037"> <li> <p>including CHM + placebo versus conventional therapy (HT) + placebo</p> </li> </ul> </li> <li> <p>CHM versus conventional therapy (drug)</p> </li> <li> <p>CHM versus another CHM (different formulations)</p> </li> <li> <p>CHM versus acupuncture</p> </li> </ul> </p> <p>See <a href="#CD009023-sec-0143">Differences between protocol and review</a> for minor changes and rationale. </p> <p>The relevant outcomes of each comparison are reported as below.</p> <p>The primary outcome was modified for clarity as changes of vasomotor symptoms including:</p> <p> <ul id="CD009023-list-0038"> <li> <p>frequency of hot flushes/night sweats;</p> </li> <li> <p>severity of hot flushes/night sweats;</p> </li> <li> <p>overall scores of hot flushes/night sweats (i.e. combination of frequency and severity);</p> </li> <li> <p>overall scores of vasomotor symptoms (i.e. combination of hot flushes and night sweats).</p> </li> </ul> </p> <p>The secondary outcomes are reported accordingly as below:</p> <p> <ul id="CD009023-list-0039"> <li> <p>menopausal symptoms measured by different instruments;</p> </li> <li> <p>adverse effects;</p> </li> <li> <p>quality of life (QoL);</p> </li> <li> <p>satisfaction of treatment.</p> </li> </ul> </p> <p>Note: see 'Difference between protocol and review' for the modifications and rationale.</p> <section id="CD009023-sec-0071"> <h4 class="title">1. Comparison of CHM versus placebo</h4> <p>Seven studies compared CHM against placebo (<a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0011" title="PlotnikoffGA , WatanabeK , TorkelsonC , LaValleurJ , RadosevichDM . The TU‐025 Keishibukuryogan for hot flash management in postmenopausal women: results and lessons for future research. MenopauseAugust 2011;18(8):886‐92. ">Plotnikoff 2011</a>; <a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>); one study compared CHM plus placebo against placebo (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>). </p> <section id="CD009023-sec-0072"> <h5 class="title">Primary outcomes</h5> <section id="CD009023-sec-0073"> <h6 class="title">1.1 Vasomotor symptoms (hot flushes/night sweats)</h6> <section id="CD009023-sec-0074"> <p><b>1.1.1 Frequency of hot flushes in a diary (daily)</b></p> <p>This reports daily hot flushes that were measured by frequency in a diary. Two studies (<a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>) reported this outcome. There was no evidence of a difference between the CHM group and the placebo group (mean difference (MD) 0.00 points, 95% confidence interval (CI) ‐0.88 to 0.89; 2 RCTs, 199 women). Heterogeneity was presented as Chi² = 0.52, df = 1 (P = 0.47); I² = 0% (<a href="./references#CD009023-fig-0006" title="">Analysis 1.1</a>; <a href="#CD009023-fig-0004">Figure 4</a>). This evidence was rated as low quality using GRADE criteria. See <a href="./full#CD009023-tbl-0001">summary of findings Table for the main comparison</a>. </p> <div class="figure" id="CD009023-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 CHM versus Placebo, outcome: 1.1 Vasomotor symptoms (hot flushes/night sweats)." data-id="CD009023-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 CHM versus Placebo, outcome: 1.1 Vasomotor symptoms (hot flushes/night sweats). </p> </div> </div> </div> </section> <section id="CD009023-sec-0075"> <p><b>1.1.2 Frequency of night sweats in a diary (daily)</b></p> <p>No data available.</p> </section> <section id="CD009023-sec-0076"> <p><b>1.1.3 Severity of hot flushes in a diary (daily)</b></p> <p>This reports daily hot flushes that were measured by severity in a diary. Only one study reported this outcome (<a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>), with a difference between the CHM group and the placebo, in favour of the CHM group (MD ‐0.70 points, 95% CI‐1.00 to ‐0.40; 1 RCT, 108 women (<a href="./references#CD009023-fig-0006" title="">Analysis 1.1</a>; <a href="#CD009023-fig-0004">Figure 4</a>). This evidence was rated as high quality using GRADE criteria. See <a href="./full#CD009023-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD009023-sec-0077"> <p><b>1.1.4 Severity of night sweats in a diary (daily)</b></p> </section> <section id="CD009023-sec-0078"> <p><b>No data available.</b></p> </section> <section id="CD009023-sec-0079"> <p><b>1.1.5 Overall scores of hot flushes in a diary (daily)</b></p> <p>This reports overall scores of hot flushes (including frequency and severity), which were measured in a diary as daily data. Data from three studies (<a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>) were suitable for meta‐analysis; they reported hot flushes with overall scores in diary. The difference in the mean overall hot flushes measured by daily record between CHM groups and the placebo groups was not significant (MD ‐0.81 points, 95% CI ‐2.08 to 0.45; 3 RCTs, 263 women), with no heterogeneity (I² = 0%) (<a href="./references#CD009023-fig-0006" title="">Analysis 1.1</a>; <a href="#CD009023-fig-0004">Figure 4</a>). This evidence was rated as low quality using GRADE criteria. See <a href="./full#CD009023-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>There was no evidence of a difference between the groups in a sensitivity analysis removing the study at other than low risk of bias (<a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>) (MD ‐1.02 points, 95% CI ‐3.80 to 1.76; 2 RCTs, 199 women). </p> <p><i>1.1.6 Overall scores of hot flushes in a diary (monthly)</i> </p> <p>This reports overall scores of hot flushes (including frequency and severity), which were measured monthly in a diary. One study (<a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>) reported a set of monthly data which was analysed accordingly, there was no difference between the two groups (MD ‐2.80 points, 95% CI ‐ 8.93 to 3.33; 1 RCT, 84 women) <a href="./references#CD009023-fig-0006" title="">Analysis 1.1</a>, <a href="#CD009023-fig-0004">Figure 4</a>. This evidence was rated as moderate using GRADE criteria. See <a href="./full#CD009023-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD009023-sec-0080"> <p><b>1.1.7 Overall scores of night sweats in a diary (daily)</b></p> <p>This reports overall night sweats (including frequency and severity), which were measured using daily recorded data. One study (<a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>) reported overall night sweats (measured daily). There was no evidence of a difference between the groups (MD 0.07 points, 95% CI ‐0.19 to 0.33; 1 RCT, 64 women) (<a href="./references#CD009023-fig-0006" title="">Analysis 1.1</a>; <a href="#CD009023-fig-0004">Figure 4</a>). This evidence was rated as moderate quality using GRADE criteria. See <a href="./full#CD009023-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD009023-sec-0081"> <p><b>1.1.8 Overall scores of night sweats in a diary (monthly)</b></p> <p>This reports overall night sweats (including frequency and severity), which were measured in a diary as monthly data. One study (<a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>) reported overall night sweats (measured monthly). There was no evidence of a difference between the groups (MD 1.30 points, 95% CI ‐1.76 to 4.36; 1 RCT, 84 women) (<a href="./references#CD009023-fig-0006" title="">Analysis 1.1</a>; Figure 4). This evidence was rated as moderate quality using GRADE criteria. See <a href="./full#CD009023-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD009023-sec-0082"> <p><b>1.1.9 Vasomotor symptoms measured by the Kupperman Index (KI) (monthly)</b></p> <p>When vasomotor symptoms (including hot flushes and night sweats) were measured monthly, different questionnaires were used. Four studies assessed overall vasomotor symptoms with the following outcome measures, including the KI (<a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>) and the Menopausal Specific Quality of Life (MENQOL) (<a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>). Data from the four studies were not suitable for meta‐analysis due to high heterogeneity when the MD was calculated (I<sup>2</sup> = 96%). Outcomes measured by KI and MENQOL were analysed separately. </p> <p>Individually, the study (<a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>) using the KI reported that overall vasomotor symptom scores were lower in the CHM group (MD ‐4.79 points, 95% CI ‐5.52 to ‐4.06; 1 RCT, 69 women). This evidence was rated as low quality using GRADE criteria. See <a href="./full#CD009023-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>Vasomotor symptoms were also measured by MENQOL in three studies (<a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>; <a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>) and there was no evidence of a difference between the groups (MD ‐0.42 points, 95% CI ‐1.52 to 0.68; 3 RCTs, 256 women); the heterogeneity was high (P = 0.002; I² = 84%) (<a href="./references#CD009023-fig-0006" title="">Analysis 1.1</a>; <a href="#CD009023-fig-0004">Figure 4</a>). This evidence was rated as low quality using GRADE criteria. See <a href="./full#CD009023-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>There was evidence of a difference between the groups in a sensitivity analysis removing the studies at other than low risk of bias (<a href="./references#CD009023-bbs2-0005" title="HainesCJ , LamPM , ChungTKH , ChengKF , LeungPC . A randomized, double‐blind, placebo‐controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climateric2008;11(3):244‐51. ">Haines 2008</a>; <a href="./references#CD009023-bbs2-0016" title="XiaY , ZhaoY , RenM , ZhangJ , WangY , ChangY , et al. A randomized double‐blind placebo controlled trial of a Cinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women. Menopause2012;19(2):234‐44. ">Xia 2012</a>) (MD ‐2.60 points, 95% CI ‐4.51 to ‐0.69; 1 RCT, 108 women). </p> </section> </section> </section> <section id="CD009023-sec-0083"> <h5 class="title">Secondary outcomes</h5> <section id="CD009023-sec-0084"> <h6 class="title">1.2 Menopausal symptoms measured monthly</h6> <p>Six studies reported monthly data, however only overall data were analysed from four studies, subset data measuring physical, psychosocial, sexual aspects from other two studies were not considered for analysis. The four studies used three different tools to measure the menopausal symptoms, the heterogeneity was very high (I<sup>2</sup> = 98%), hence, results were unpooled, instead, subtotal analysis was chosen, given that different measurements were adopted (<a href="./references#CD009023-fig-0007" title="">Analysis 1.2</a>). </p> <p>One study (<a href="./references#CD009023-bbs2-0020" title="ZhongLLD , TongY , TangGWK , ZhangZJ , ChoiWK , ChengKL , et al. A randomized, double‐blind, controlled trial of a Chinese herbal formula (Er‐Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause2013;20(7):1‐10. ">Zhong 2013</a>) assessing the overall scores measured by Menopausal Specific Quality of Life Questionnaire (MENQOL, scale 0 to 6) demonstrated a difference between the comparison groups (MD ‐11.70 points, 95% CI ‐18.98 to ‐4.42; 108 women) (<a href="./references#CD009023-fig-0007" title="">Analysis 1.2</a>). This study also used the Menopause Rating Scale<b>(</b>MRS) to measure overall menopausal symptoms, but this was not included in our analysis to avoid over counting. </p> <p>Data from the studies using the Kupperman Index (KI, overall scores, scale 0 to 3) were not suitable for meta‐analysis due to high heterogeneity (Chi² = 9.52, df = 1 (P &lt; 0.002), I² = 89%). Individually, Lou and colleagues (<a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>) and Zhou and colleagues (<a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>) reported that CHM was better than placebo in improving the monthly overall menopausal symptom scores (MD ‐8.22 points, 95% CI ‐9.22 to ‐7.22; 1 RCT, 110 women and MD ‐12.61 points, 95% CI ‐15.21 to ‐10.01; 1 RCT, 99 women, respectively). </p> <p>One study (<a href="./references#CD009023-bbs2-0014" title="van derSluijsCP , BensoussanA , ChangS , BaberR . A randomized placebo‐controlled trial on the effectiveness of an herbal formula to alleviate vasomotor symptoms. Menopause2009;16(2):336‐44. ">van der Sluijs 2009</a>) did not find any evidence of a difference between the two groups when overall menopausal symptoms were measured by the Hot Flash‐Related Daily Interference Scale (HFRDI, scale 0 to 10) (MD 1.58 points, 95% CI ‐6.42 to 9.58; 1 RCT, 92 women) (<a href="./references#CD009023-fig-0007" title="">Analysis 1.2</a>). </p> <p>In summary, measures of overall menopausal symptoms were unsuitable for pooling due to high heterogeneity, and findings were inconsistent. When menopausal symptoms were compared by using the KI and MENQOL, there was some suggestion of improvement in the three studies, however there was little evidence of a difference between the groups in the fourth study, which used the HFDRI. </p> </section> <section id="CD009023-sec-0085"> <h6 class="title">1.3 Improvement in menopausal symptoms</h6> <p>Improvement in menopausal symptoms: this was reported in one Chinese study and was treated as dichotomous data (<a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>), the study showed a difference between CHM and placebo, favouring CHM (risk ratio (RR) 1.46; 95% CI 1.13 to 1.89; 1 RCT, 110 women) (<a href="./references#CD009023-fig-0008" title="">Analysis 1.3</a>). </p> </section> <section id="CD009023-sec-0086"> <h6 class="title">1.4 Adverse effects</h6> <p>All seven studies (705 women) reported adverse effects as one of the study outcomes. A total of 61 adverse events were reported in 412 women assigned to CHM and 32 adverse events in 293 women assigned to placebo. Two studies claimed no adverse events occurred which was not estimable in analysis (<a href="./references#CD009023-bbs2-0010" title="LouHY , HuangD , FangSH , ZhaoXF , HuangQX , WangMZ . Clinical study on XianLing GuBao capsule in patients with menopausal syndrome. China Journal of Chinese Malteria Medice 2009,11;34(22):2950‐2. ">Lou 2009</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>). There was no evidence of a difference between the groups (RR 1.51; 95% CI 0.69 to 3.33; 7 RCTs, 705 women, I² = 48%). (<a href="./references#CD009023-fig-0009" title="">Analysis 1.4</a>). </p> </section> <section id="CD009023-sec-0087"> <h6 class="title">1.5 Quality of life (QoL)</h6> <p>No study reported the QoL specifically in the comparison of CHM versus placebo. One study (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>), explored a model of a trial with a double‐dummy design; the data were split into two comparisons, CHM plus placebo versus placebo, and CHM plus placebo versus HT plus placebo. </p> <p>Quality of life was assessed by SF‐36 (0 to 100 scale). Data in the published report were not available, but were successfully retrieved when the author was contacted. There was no evidence of a difference between the two groups (MD 10.60 points, 95% CI ‐3.66 to 24.86; 1 RCT, 20 women) (<a href="./references#CD009023-fig-0010" title="">Analysis 1.5</a>). </p> </section> <section id="CD009023-sec-0088"> <h6 class="title">1.6 Satisfaction with treatment</h6> <p>No study reported this outcome.</p> </section> </section> </section> <section id="CD009023-sec-0089"> <h4 class="title">2. Comparison of CHM versus no treatment</h4> <p>No study was found for inclusion in the review.</p> </section> <section id="CD009023-sec-0090"> <h4 class="title">3. Comparison of CHM plus drug versus placebo plus drug</h4> <p>Only one study used this comparison model (<a href="./references#CD009023-bbs2-0013" title="TaoL , MaX , ChenK . Clinical study on effect of Qingxuan Tiaoya Recipe in treating menopausal women with hypertension [清眩调压方治疗更年期女性高血压病的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine 2009.8;29(8):680‐4. ">Tao 2009</a>), but no data were available on primary and secondary outcomes. </p> </section> <section id="CD009023-sec-0091"> <h4 class="title">4. Comparison of CHM versus conventional therapy (HT)</h4> <p>Nine studies compared CHM against HT as an active comparison (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>; <a href="./references#CD009023-bbs2-0021" title="ZhouJ , QuF , NanR , TangD . The effect of Chinese medicinal herbs in relieving menopausal symptoms in ovariectomized Chinese women.. Explore2007;3(5):478‐84. ">Zhou 2007</a>); one study compared CHM plus placebo against HT plus placebo (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>). </p> <section id="CD009023-sec-0092"> <h5 class="title">Primary outcomes</h5> <p><b>4.1 Vasomotor symptoms</b> </p> <p>No data were available for these primary outcomes: frequency of daily hot flushes; frequency of daily night sweats; severity of daily hot flushes; severity of daily night sweats; overall scores of daily hot flushes; overall scores of daily night sweats measured in a diary. </p> <section id="CD009023-sec-0093"> <h6 class="title">4.1.1 Vasomotor symptoms measured by the MENQOL (monthly)</h6> <p>Data from two studies (<a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>) which measured monthly vasomotor symptoms by MENQoL were suitable for meta‐analysis. However, pooling their data showed no evidence of a difference between the groups in the monthly overall vasomotor symptom scores (MD 0.47 points; 95% CI ‐0.50 to 1.44; 2 RCTs, 127 women). Heterogeneity was presented as Chi² = 4.72, df = 1 (P = 0.03); I² = 79% ,which means the heterogeneity across two included studies was moderately high (<a href="./references#CD009023-fig-0011" title="">Analysis 2.1</a>; <a href="#CD009023-fig-0005">Figure 5</a>). This evidence was rated as very low quality: see <a href="./full#CD009023-tbl-0002">summary of findings Table 2</a>. </p> <div class="figure" id="CD009023-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 CHM versus Conventional Therapy (HT), outcome: 2.1 Vasomotor symptoms (hot flushes/night sweats)." data-id="CD009023-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 CHM versus Conventional Therapy (HT), outcome: 2.1 Vasomotor symptoms (hot flushes/night sweats). </p> </div> </div> </div> <p>We planned a sensitivity analysis based on study quality but did not perform this as both studies in this analysis were at high risk of bias in at least one identified domain. </p> </section> </section> <section id="CD009023-sec-0094"> <h5 class="title">Secondary outcomes</h5> <section id="CD009023-sec-0095"> <h6 class="title">4.2 Menopausal symptoms measured monthly</h6> <p>Five studies assessed the monthly menopausal symptoms by using different scoring systems. Three studies used the KI scale (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>) and two studies used the MENQOL (<a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>). Two studies also assessed menopausal symptoms based on individual aspects including the psychosocial component, sexual and physical functions by the MENQOL (<a href="./references#CD009023-bbs2-0003" title="GongL , ZhangS , JiL . Effect of hormone and Chinese Traditional Medicine treatment on cognition and memory and quality of life in the women at the early stage of menopause [绝经早期激素与中药治疗对认知记忆和生存质量的影响]. Reproduction and Contraception2008;28(1):26‐31. ">Gong 2008</a>; <a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>), however this was not considered in analysis to avoid double counting. </p> <p>The data from these five studies were considered unsuitable for meta‐analysis using the standardised mean difference (SMD), due to high heterogeneity (I² = 86%). When the data for studies using the KI were pooled, heterogeneity remained high (Chi² = 10.79, df = 2 (P = 0.005); I² = 81%) and there was no evidence of a difference between the groups (MD ‐1.24 points; 95% CI ‐3.99 to 1.52; 3 RCTs, 642 women). When the studies using the MENQOL were pooled, heterogeneity was moderate (Chi² = 2.17, df = 1 (P = 0.14); I² = 54%), there was also no evidence of a difference between the groups (MD ‐1.83 points, 95% CI ‐7.00 to 3.34; 2 RCTs, 285 women) (<a href="./references#CD009023-fig-0012" title="">Analysis 2.2</a>). </p> </section> <section id="CD009023-sec-0096"> <h6 class="title">4.3 Improvement in menopausal symptoms</h6> <p>For assessing the dichotomous data from improvement in menopausal symptoms concerning the overall menopausal symptoms in the three Chinese studies (<a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>), a pooled result suggested there was a difference between CHM and HT, in favour of CHM (RR 1.17; 95% CI 1.04 to 1.32; 3 RCTs, 833 women). Heterogeneity across these three studies was acceptable: Chi² = 5.59, df = 2 (P = 0.06), I² = 64% (<a href="./references#CD009023-fig-0013" title="">Analysis 2.3</a>). </p> </section> <section id="CD009023-sec-0097"> <h6 class="title">4.4 Adverse effects</h6> <p>Six studies (864 women) out of nine studies reported adverse effects. A total of 23 adverse events were reported in the 463 women assigned to CHM and 24 adverse events in the 401 women assigned to HT. Four studies claimed no adverse events, which was not estimable in analysis (<a href="./references#CD009023-bbs2-0001" title="AziziH , LiuYF , DuL , WangCH , Bahrami‐TaghanakiH , EsmailyHO , et al. Menopause‐related symptoms: traditional Chinese medicine vs hormone therapy. Alternative Therapies in Health and MedicineJul/Aug 2011;17(4):48‐53. ">Azizi 2011</a>; <a href="./references#CD009023-bbs2-0002" title="DengW , HuangH , ZengD , LiX , ZhangJ , ShaoY , et al. Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [补肾壮骨冲剂对更年期综合征患者性激素及血脂的影响]. Journal of Traditional Chinese Medicine2011;52(3):208‐13. ">Deng 2011</a>; <a href="./references#CD009023-bbs2-0008" title="LiX , DengW , ZhangJ , ZhouL , HuangW . Effect of bushen zhuanggu granule on the gonadal hormone and blood lipid metabolism in climacteric women [补肾壮骨冲剂对围绝经期妇女性激素及血脂代谢的影响]. Chinese Journal of Integrated Traditional and Western Medicine2009;29(7):599‐602. ">Li 2009</a>; <a href="./references#CD009023-bbs2-0012" title="QuF , CaiX , GuY , ZhouJ , ZhangR , BurrowsE , et al. Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. Journal of Alternative and Complementary Medicine2009;15(1):93‐100. ">Qu 2009</a>). Our findings are compatible with a higher risk of adverse events in either arm, or with no difference between the groups, so no conclusions can be drawn (RR 0.96; 95% CI 0.66 to 1.39; 6 RCTs, 864 women). Heterogeneity was presented as Chi² = 0.22, df = 1 (P = 0.64, I² = 0%), which means that there was no heterogeneity; however the confidence interval was wide, hence, we failed to draw an absolute conclusion on the safety of CHM (<a href="./references#CD009023-fig-0014" title="">Analysis 2.4</a>). Three studies did not mention adverse effects (<a href="./references#CD009023-bbs2-0006" title="JingS , WeiM . Clinical study on relationship between memory quotient, estrogen and Chinese nourishing kidney herbs in perimenopausal women [围绝经期妇女的记忆商与雌激素及补肾中药之间关系的临床研究]. Chinese Journal of Integrated Traditional and Western Medicine2002;22(7):494‐5. ">Jing 2002</a>; <a href="./references#CD009023-bbs2-0009" title="LiangR , ChenM , XuXi , PanZ , HuX , ZhouS , et al. Effect of dandi tablet on blood lipids and sex hormones in women of postmenopausal stage [丹地片对绝经后女性血脂及性激素的影响]. Chinese Journal of Integrated Traditional and Western Medicine2003;23(8):593‐5. ">Liang 2003</a>; <a href="./references#CD009023-bbs2-0015" title="WuS , MaY , OuX , LiD . Research and analysis of 180 cases of patients with the climacteric syndrome treated by herbal paste intervention [膏滋干预脾肾阳虚型更年期综合征180例研究分析]. Medical Innovation of China [Zhong Guo Yi Xue Chuang Xing]2013;10(25):1‐2. ">Wu 2013</a>). </p> </section> <section id="CD009023-sec-0098"> <h6 class="title">4.5 Quality of life</h6> <p>Only one study (<a href="./references#CD009023-bbs2-0022" title="ZhouLL , XuLZ , LiuHW , ZhangJ , LiuY , LiuXF , et al. The effect of QOL and cost‐utility analysis on sex hormone and Chinese medicine in women with early postmenopausal. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University]2009;29(11):2181‐6. ">Zhou 2009</a>) assessed the quality of life by using the MENQOL; the data showed no evidence of a difference between the two groups (MD 2.42 points; 95% CI ‐5.34 to 10.18, 1 RCT, 57 women) (<a href="./references#CD009023-fig-0015" title="">Analysis 2.5</a>). </p> <p>A comparison of CHM plus placebo versus HT plus placebo was set up in one study (<a href="./references#CD009023-bbs2-0007" title="KweeSH , TanHH , MarsmanA , WautersC . The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. Maturitas2007;58(1):83‐90. ">Kwee 2007</a>) and assessed QoL by using the Short Form (36) Health Survey (SF‐36, 0 to 100 scale), it showed no evidence of a difference between the groups (MD ‐0.10 points, 95% CI ‐12.95 to 12.75; 1 RCT, 21 women) (<a href="./references#CD009023-fig-0016" title="">Analysis 2.6</a>). </p> </section> <section id="CD009023-sec-0099"> <h6 class="title">4.5 Satisfaction of treatment</h6> <p>No study reported this outcome.</p> </section> </section> </section> <section id="CD009023-sec-0100"> <h4 class="title">5. Comparison of CHM versus conventional therapy (fluoxetine &amp; estazolam)</h4> <p>This compares drugs other than HT, and was reported in the two included studies (<a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>). These two studies compared CHM against either fluoxetine (<a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>) or estazolam (<a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>). </p> <section id="CD009023-sec-0101"> <h5 class="title">Primary outcomes</h5> <section id="CD009023-sec-0102"> <h6 class="title">5.1 Vasomotor symptoms</h6> <p>Data not available.</p> </section> </section> <section id="CD009023-sec-0103"> <h5 class="title">Secondary outcomes</h5> <section id="CD009023-sec-0104"> <h6 class="title">5.2 Menopausal symptoms</h6> <p>Data not available.</p> </section> <section id="CD009023-sec-0105"> <h6 class="title">5.3 Adverse effects</h6> <p>Two studies were suitable for pooling (<a href="./references#CD009023-bbs2-0018" title="ZhangG , ZhangG , AiC , XieY , ZhaoW , YueC . Clinical observation of 38 cases involutional depression treated by Zaoren Buxue decoction together with fluoxetine [枣仁补血汤联合氟西汀治疗更年期抑郁症38 例临床观察]. Beijing Journal of Traditional Chinese Medicine 2009.11;28(11):873‐4. ">Zhang 2009</a>; <a href="./references#CD009023-bbs2-0019" title="ZhangW , LiuQ , ZhangZ , HuangT , CaiZ . Randomized control research on theory of Yunqi in differentiating and treating menopausal insomnia of liver‐kidney deficiency pattern [基于运气学说辨治肝肾亏虚型更年期失眠症的随机对照研究]. Shanghai Journal of Traditional Chinese Medicine2012;46(3):51‐3. ">Zhang 2012</a>), however the heterogeneity across these studies was still moderately high (Chi² = 2.56, df = 1 (P = 0.11); I² = 61%). There was no evidence of a difference in adverse effects between CHM and conventional medications (RR 0.20; 95% CI 0.03 to 1.17; 2 RCTs, 139 women) (<a href="./references#CD009023-fig-0017" title="">Analysis 3.1</a>). </p> </section> <section id="CD009023-sec-0106"> <h6 class="title">5.4 Quality of life</h6> <p>Data not available.</p> </section> <section id="CD009023-sec-0107"> <h6 class="title">5.5 Satisfaction with treatment</h6> <p>Data not available.</p> </section> </section> </section> <section id="CD009023-sec-0108"> <h4 class="title">6. Comparison of CHM versus another CHM (different formulations)</h4> <p>Two studies (<a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>) that assessed different CHM formulations were included and analysed. One study (<a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>) investigated whether a self‐designed experimental formula called <i>Shen Qi Wu Wei Zi</i> decoction was more effective than a control formula, which was either <i>Zuo Gui Yin</i> or <i>You Gui Yin.</i> Both are classical formulations, depending on a TCM diagnosis labelled as Yin‐deficiency pattern or Yang‐deficiency pattern. </p> <p>The other study (<a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>) assessed <i>Geng Mei Ning,</i> a self‐designed formulation, against an over‐the‐counter product, <i>Geng Nian Ning.</i> </p> <p><b>Primary outcomes</b> </p> <p><b>6.1 Vasomotor symptoms</b> </p> <p>Data not available.</p> <section id="CD009023-sec-0109"> <h5 class="title">Secondary outcomes</h5> <section id="CD009023-sec-0110"> <h6 class="title">6.2 Improvement in menopausal symptoms</h6> <p>Two studies (<a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>; <a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>) reported the data in dichotomous style assessing improvement in menopausal symptoms; in addition, one study (<a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>) assessed the improvement in menopausal symptoms in relation to TCM diagnostic pattern scores. </p> <p>Pooling would be inappropriate for head‐to‐head comparisons using different herbal formulations (Chi² = 38.99, df = 1 (P &lt;0.00001); I² = 97%) (<a href="./references#CD009023-fig-0018" title="">Analysis 4.1</a>). </p> <p>Individually, one study (<a href="./references#CD009023-bbs2-0004" title="GuoM , ShengY . Clinical observation of 65 cases in menopausal syndrome with TCM syndrome differentiation and treatment [中医辨证治疗更年期综合征65例临床观察]. Journal of Traditional Chinese Medicine2009;50(Supplement):167‐8. ">Guo 2009</a>) did not demonstrate any evidence of a difference in overall success rate between the two different CHM formulations (RR 0.97; 95% CI 0.91 to 1.03; 1 RCT, 130 women). One of the two studies (<a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>), reported the experimented CHM, <i>Geng Mei Ning</i> , was superior to the control CHM, <i>Geng Nian Ning</i> (RR 1.46; 95% CI 1.10 to 1.94; 1 RCT, 231 women) (<a href="./references#CD009023-fig-0018" title="">Analysis 4.1</a>). Xue and colleagues (<a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>) also used another assessment tool, TCM diagnostic pattern score to assess changes in menopausal symptoms. It showed evidence of a difference between comparisons with different CHM formulations in favour of the experimental formula, <i>Geng Mei Ning</i> (RR 1.52; 95% CI 1.16 to 2.00; 1 RCT, 231 women) (<a href="./references#CD009023-fig-0019" title="">Analysis 4.2</a>). </p> <p>Formula compositions in detail are provided in the <a href="./references#CD009023-sec-0145" title="">Characteristics of included studies</a> tables. </p> </section> <section id="CD009023-sec-0111"> <h6 class="title">6.3 Adverse effects</h6> <p>Only one study (<a href="./references#CD009023-bbs2-0017" title="XueS , ZhangQ , JiangX , JinZ . Effect of bushen zhuanggu granules upon gonadal hormone and blood fat in climacteric females [更美宁胶囊治疗更年期综合征的多中心临床研究]. Traditional Chinese Drug Research ＆ Clinical Pharmacology2011;22(1):117‐20. ">Xue 2011</a>) mentioned there were no adverse events observed in either comparison group. </p> </section> <section id="CD009023-sec-0112"> <h6 class="title">6.4 Quality of life</h6> <p>Data not available.</p> </section> <section id="CD009023-sec-0113"> <h6 class="title">6.5 Satisfaction of treatment</h6> <p>Data not available.</p> </section> </section> </section> <section id="CD009023-sec-0114"> <h4 class="title">7. Comparison of CHM versus acupuncture</h4> <p>No data available.</p> <section id="CD009023-sec-0115"> <h5 class="title">Subgroup analysis</h5> <p>We did not perform subgroup analyses because there were not enough studies to estimate effects in subgroups in any comparison. </p> </section> <section id="CD009023-sec-0116"> <h5 class="title">Funnel plots</h5> <p>Due to the small number of studies in any comparison, we did not perform funnel plots.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009023-sec-0117" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009023-sec-0117"></div> <section id="CD009023-sec-0118"> <h3 class="title" id="CD009023-sec-0118">Summary of main results</h3> <p>Data were assessed and findings were reported in line with the rigorous scientific research ideologies and consideration of the fundamental philosophies employed in traditional Chinese medicine (TCM). </p> <p><b>Summary of findings</b> </p> <p>This systematic review of Chinese herbal medicine (CHM) for menopausal symptoms was based on 22 RCTs. There were 2902 perimenopausal and postmenopausal women from different ethnic backgrounds with 90% from a Chinese background. Diagnosis was based on assessment of menopausal scores across the 22 included studies, while nine of the studies also utilised an additional Chinese medicine diagnostic tool. </p> <p>Except for two studies that evaluated one Chinese herbal formula, 20 trials studied different formulations which consisted of different ingredients with a total of 91 experimented herbs. Amongst them there were 11 of the most commonly used herbs which are very consistent with the clinical literature resources and contemporary clinical practice. Placebo, hormone therapy (HT) and other types of conventional drugs as well as another herbal formula were used as comparisons, however, the majority of the studies used placebo (8/22 studies) and HT (10/22 studies) as a control, this includes one study that used both placebo and HT as controls. </p> <p>It was noted that when a style of herbal intervention was considered in these included studies, neither a single herb, nor a complete tailored approach (which is the most standard TCM practice) was used. The majority of studies used a standard formula throughout the trial, which is a reflection of the reconciliation between the rigorous scientific methodology and the fundamental TCM philosophies as an effort of integration in contemporary Chinese medicine research. </p> <p>The most popular length of intervention was 12 weeks, with a few trials having one to four weeks lead‐in period and four to 12 weeks follow‐up. The majority of the interventions used CHM extract in the form of granules. </p> <p>Although the quality of study design was relatively good as far as many similar CHM clinical trials other than in the area of hot flushes were concerned, there were still serious flaws in the study designs. A large proportion of the included studies (16/22) did not report how allocation concealment was carried out; less than 50% of studies (10/22) were double‐blind trials which influenced partially the primary outcome with less impact on some of secondary outcomes such as changes in the levels of hormones and lipids. Placebo seemed to be used appropriately in terms of its identical appearance and taste to CHM. Intention‐to‐treat (ITT) was not implemented appropriately, only 13/22 studies considered missing and incomplete data. Nevertheless, reporting bias was relatively low, since the majority of studies reported expected outcomes. Many studies did not report full compositions, or full dosages of the investigated formulations, or both. No other potential bias was detected across the included studies. </p> <p>Several different common menopausal symptoms scores were used. This included numerical results from an individual or a combination of menopausal symptoms and dichotomous data from a combination of menopausal symptoms. A few studies used the same outcome measure such as the Kupperman Index (KI), Menopause‐Specific Quality of Life (MENQOL), Greene Climacteric Scale (GCS) and Menopause Rating Scale (MRS). However for statistical analysis, data were entered and analysed separately, in order to best address the heterogeneity caused by the diversity in terms of assessment tools. </p> <p>Findings of the CHM effects on menopausal symptoms were summarised in the following aspects. </p> <p><b>Vasomotor symptoms:</b> Meta‐analysis of the pooled data found CHM was no better than placebo for vasomotor symptoms measured by frequency and severity of daily hot flushes, and overall scores of vasomotor symptoms by a specific questionnaire. The evidence was rated from low to moderate grade. </p> <p>With HT as control intervention, pooled continuous data did not show any difference in the overall vasomotor symptoms between the CHM and HT with no data available on the other defined aspects of vasomotor symptoms. The evidence was rated as very low grade. </p> <p>The rest of defined comparisons reported no data on the primary outcome, i.e. vasomotor symptoms. </p> <p><b>Menopausal symptoms:</b> Meta‐analysis of the pooled monthly menopausal symptom scores showed no difference between CHM and HT in continuous data; however the pooled monthly menopausal symptoms scores in dichotomous data set suggested a difference between CHM and HT, in favour of CHM. No pooled data were available from other comparisons on menopausal symptoms. </p> <p><b>Adverse effects:</b> The majority of the studies (17 out of 22) evaluated adverse effects; overall, the Chinese herbal formulae were well‐tolerated based on the clinical adverse effects events and the relevant laboratory examinations (haematological and biochemical). Most adverse effects reported were mild to moderate including diarrhoea, tenderness of the breasts, gastric discomfort, and the unfavourable taste of the CHM. The adverse effects symptoms were resolved once the CHM was terminated. Meta‐analysis of the pooled adverse effects in the dichotomous data set showed no difference between CHM and placebo or in the comparisons between CHM and HT or drugs. In summary, it is reasonable to conclude that CHM did not present any higher risk of adverse effects compared with HT, placebo and some pharmaceutical drugs. </p> <p><b>Quality of life:</b> Only two studies evaluated this outcome measure by using either the MENQOL or SF‐36. There was no difference between CHM plus placebo and placebo groups. </p> <p><b>Satisfaction of treatment:</b> no study assessed this outcome. </p> <p><b>Other outcomes:</b> There was a tendency that studies conducted in China were more likely to assess the hormone levels including serum FSH, LH, E<sub>2</sub> and/or progesterone for exploring any possible mechanisms of effectiveness. However these were not outcomes of interest to this review and we have not reported them. </p> </section> <section id="CD009023-sec-0119"> <h3 class="title" id="CD009023-sec-0119">Overall completeness and applicability of evidence</h3> <p>The objective of this review was to evaluate the effectiveness and safety of CHM in perimenopausal and postmenopausal women using the same research methods across the included studies. The participants were perimenopausal and postmenopausal women; various formulae with 11 of the most commonly used herbs investigated with a standard approach. The range of intervention periods varied widely from four weeks to 106 weeks, with the most common duration being 12 weeks. The most commonly used form of herbs is herbal extract as granules for practical purposes. Outcome measures assessed included frequency and intensity of daily hot flushes and night sweats, monthly menopausal symptoms scores, adverse effects, quality of life which were consistent with current practice in menopause research. </p> <p>However, incomplete reports on formula compositions and dosages, paucity of data on the number of women experiencing adverse events, substantial heterogeneity for primary and secondary outcome measures, flaws in design leading to high risk of bias in allocation, blinding, incomplete outcome data and selective reporting issues made the results inconclusive. Thus, the completeness and applicability of the evidence is limited. </p> <p>Furthermore, the formulations and herbs varied; there were 21 formulae with 91 herbal ingredients. This limits the applicability of findings in general practice of Chinese herbal medicine, since there are many more formulae and herbs that were not tested in the included studies but are commonly used in day‐to‐day practice. Assessment of an individual's constitution which is often interpreted as Chinese medicine diagnostic patterns also influences applicability of the evidence in this review. For the consumer, it is very important to seek professional advice from a qualified Chinese medicine practitioner. </p> <p>In addition, the majority of participants were of Chinese background, so results should be interpreted with caution when applied to other ethnic groups. </p> </section> <section id="CD009023-sec-0120"> <h3 class="title" id="CD009023-sec-0120">Quality of the evidence</h3> <p>The quality of the evidence for CHM for menopausal symptoms was affected by inadequate reporting of study methods. <a href="#CD009023-fig-0002">Figure 2</a> and <a href="#CD009023-fig-0003">Figure 3</a> indicate the methodological quality of the trials included in this review based on the review authors' judgements. Many studies did not report full compositions or full dosages of the investigated formulations. Therefore, the quality of the evidence was impacted potentially by the presence of selection bias, performance bias, attrition bias and reporting bias. The quality of the evidence was also influenced by the unexplained high level of heterogeneity between studies, types of herbs experimented and the paucity of data on the number of women experiencing adverse events. Using GRADE criteria, the quality of the body of evidence for comparison of CHM versus placebo was rated from moderate to very low for effectiveness. See <a href="./full#CD009023-tbl-0001">summary of findings Table for the main comparison</a>. The quality of the evidence for the comparison of CHM versus HT was rated very low for effectiveness outcomes. See <a href="./full#CD009023-tbl-0002">summary of findings Table 2</a>. The quality of the evidence for adverse effects from above comparisons was graded very low. </p> </section> <section id="CD009023-sec-0121"> <h3 class="title" id="CD009023-sec-0121">Potential biases in the review process</h3> <p>It is notable that there were a few limitations to this review. Although the search strategy was comprehensive, it is possible that some unpublished reports or studies published in languages other than English and Chinese could have been unintentionally missed. Therefore language and publication bias cannot be excluded entirely. Furthermore, the heterogeneity of measures used and study materials tested in the included studies made it difficult to compare across the included studies. The expanded defined outcomes in the review stage may introduce bias in reporting the results. </p> </section> <section id="CD009023-sec-0122"> <h3 class="title" id="CD009023-sec-0122">Agreements and disagreements with other studies or reviews</h3> <p>The main findings of this review do not completely echo the results from previous reviews (<a href="./references#CD009023-bbs2-0067" title="PengW , SibbrittDW , HickmanL , KongX , YangL , AdamsJ . A critical review of traditional Chinese medicine use amongst women with menopausal symptoms. Climacteric : the journal of the International Menopause Society2014;17(6):635‐44. [PUBMED: 24678630] ">Peng 2014</a>; <a href="./references#CD009023-bbs2-0076" title="Taylor‐SwansonL , ThomasA , IsmailR , SchnallJ G , CrayS L , MitchellE S , WoodsN F . Effects of traditional Chinese medicine on symptoms clusters during the menopausal transition. Climacteric2015;18(2):142‐56. ">Taylor‐Swanson 2014</a>; <a href="./references#CD009023-bbs2-0078" title="XieY , ZhuY , WuT . Effects and safety of traditional Chinese medicine for treating postmenopausal Osteoporosis: a systematic review. Chinese Journal of Evidence‐Based Medicine2005;5(1):20. ">Xie 2005</a>; <a href="./references#CD009023-bbs2-0079" title="XuLW , JiaM , SalchowR , KentschM , CuiXJ , DengHY , et al. Efficacy and side effects of Chinese herbal medicine for menopausal symptoms: a critical review. Evidence‐Based Complementary and Alternative Medicine2012; Vol. 2012:Article ID 568106.19 pages. [PUBMED: 23365599] ">Xu 2012</a>). Whilst this review is likely the most comprehensive systematic review with meta‐analysis, it found little evidence that CHM was any more or less efficacious for the management of menopausal symptoms compared to placebo or HT. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009023-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) flow‐chart of study selection." data-id="CD009023-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) flow‐chart of study selection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009023-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009023-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 CHM versus Placebo, outcome: 1.1 Vasomotor symptoms (hot flushes/night sweats)." data-id="CD009023-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 CHM versus Placebo, outcome: 1.1 Vasomotor symptoms (hot flushes/night sweats). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 CHM versus Conventional Therapy (HT), outcome: 2.1 Vasomotor symptoms (hot flushes/night sweats)." data-id="CD009023-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 CHM versus Conventional Therapy (HT), outcome: 2.1 Vasomotor symptoms (hot flushes/night sweats). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 1 Vasomotor symptoms (hot flushes/night sweats)." data-id="CD009023-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 1 Vasomotor symptoms (hot flushes/night sweats).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 2 Menopausal symptoms measured monthly." data-id="CD009023-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 2 Menopausal symptoms measured monthly.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 3 Improvement in menopausal symptoms." data-id="CD009023-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 3 Improvement in menopausal symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 4 Adverse effects." data-id="CD009023-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 4 Adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 5 QoL by SF‐36." data-id="CD009023-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 5 QoL by SF‐36.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus conventional therapy (HT), Outcome 1 Vasomotor symptoms (hot flushes/night sweats)." data-id="CD009023-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 CHM versus conventional therapy (HT), Outcome 1 Vasomotor symptoms (hot flushes/night sweats). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus conventional therapy (HT), Outcome 2 Menopausal symptoms measured monthly." data-id="CD009023-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 CHM versus conventional therapy (HT), Outcome 2 Menopausal symptoms measured monthly. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus conventional therapy (HT), Outcome 3 Improvement in menopausal symptoms." data-id="CD009023-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 CHM versus conventional therapy (HT), Outcome 3 Improvement in menopausal symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus conventional therapy (HT), Outcome 4 Adverse effects." data-id="CD009023-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 CHM versus conventional therapy (HT), Outcome 4 Adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus conventional therapy (HT), Outcome 5 QoL by MENQOL." data-id="CD009023-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 CHM versus conventional therapy (HT), Outcome 5 QoL by MENQOL.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus conventional therapy (HT), Outcome 6 QoL by SF‐36." data-id="CD009023-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 CHM versus conventional therapy (HT), Outcome 6 QoL by SF‐36.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 CHM versus conventional therapy (fluoxetine &amp; estazolam), Outcome 1 Adverse effects." data-id="CD009023-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 CHM versus conventional therapy (fluoxetine &amp; estazolam), Outcome 1 Adverse effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 CHM versus another CHM (different formulations), Outcome 1 Improvement in menopausal symptoms (general)." data-id="CD009023-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 CHM versus another CHM (different formulations), Outcome 1 Improvement in menopausal symptoms (general). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009023-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/urn:x-wiley:14651858:media:CD009023:CD009023-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_t/tCD009023-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 CHM versus another CHM (different formulations), Outcome 2 Improvement in menopausal symptoms (TCM diagnostic patterns)." data-id="CD009023-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 CHM versus another CHM (different formulations), Outcome 2 Improvement in menopausal symptoms (TCM diagnostic patterns). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/media/CDSR/CD009023/image_n/nCD009023-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009023-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Chinese herbal medicine (CHM) compared with placebo for menopausal symptoms</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Findings of Effectiveness (Primary outcome)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> women with menopausal symptoms<br/> <b>Settings:</b> Community<br/> <b>Intervention:</b> CHM<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Assumed risk</b> </p> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> <p><b>CHM compared to placebo</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>Frequency of hot flushes measured in a diary (daily)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean</p> <p>frequency of hot flushes</p> <p>in the control groups</p> <p>ranged across control groups from<br/> ‐2.81 to 2.4 points in a diary </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean frequency of hot flushes was 0 points flushes per day more in the CHM groups than in placebo group (0.88 to 0.89 points more flushes) in a diary. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>199<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝</p> <p>MODERATE <sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A lower score means less bothersome hot flushes</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>Severity of hot flushes measured in a diary (daily)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean severity of hot flushes in the control groups was<br/> 2.3 points in a diary. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean severity of hot flushes was 0.70 points lower in the CHM group than in the placebo group (1.00 lower to 0.40 lower) in a diary. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>108<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝</p> <p>MODERATE <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A lower score means less bothersome hot flushes</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>Overall scores of hot flushes in a diary (daily)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall hot flush scores (frequency and severity)</p> <p>in the control groups</p> <p>ranged across control groups from<br/> ‐5.15 to 7.0 scores in a diary </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall hot flush scores (frequency and severity) in the CHM groups was 0.81 scores lower (2.08 lower to 0.45 higher) in a diary. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>263<br/> (3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW<sup>1 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A lower score means less bothersome hot flushes</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>Overall scores of hot flushes in a diary (monthly)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall vasomotor symptoms (hot flushes/night sweats)</p> <p>in the control groups</p> <p>was 7.9 points</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall vasomotor symptoms (hot flushes/night sweats) was 2.8 points lower in the CHM group than in placebo group (8.93 fewer to 3.33 more) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p>VERY LOW <sup>4,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A lower score means less bothersome hot flushes</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>Overall night sweats in a diary (daily)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall daily night sweat score (frequency and severity)</p> <p>in the control groups</p> <p>was 0.42 in a diary</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall daily night sweat score (frequency and severity) in the CHM group was 0.07 higher (0.19 lower to 0.33 higher) than in placebo in a diary </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p>LOW <sup>1,6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A lower score means less bothersome night sweats</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>Overall scores of night sweats in a diary (monthly)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall monthly night sweats (frequency and severity)</p> <p>in the control groups</p> <p>was 1.9 points</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean overall monthly night sweats (frequency and severity) was 1.3 points higher in the CHM group (1.76 fewer to 4.36 more) than in placebo </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p>VERY LOW <sup>4,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A lower score means less bothersome night sweats</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor Symptoms<br/> <b>measured by the Kupperman Index (KI, monthly)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean vasomotor symptom scores</p> <p>in the control groups</p> <p>was 6.81 scores</p> <p>on an 11‐item questionnaire</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean vasomotor symptom scores was<br/> 4.79 points lower in the CHM group (5.52 lower to 4.06 lower) than in placebo, on an 11‐item questionnaire. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p>LOW <sup>2, 7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>KI is a 11‐item questionnaire with scale from 0 to 3. A lower score means fewer symptoms.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vasomotor Symptoms<br/> <b>measured by Menopause Specific Quality of Life Questionnaire (MENQOL, monthly)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean vasomotor symptom scores</p> <p>in the control groups</p> <p>ranged across control groups from<br/> 1.73 to 7.9 points on </p> <p>an 29‐item questionnaire</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean vasomotor symptom scores was 0.42 points lower in the CHM group (1.52 lower to 0.68 higher) than in placebo, on an 29‐item questionnaire. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MENQOL is a 29‐item questionnaire with scale from 0 to 6. A lower score means fewer symptoms. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse Effects</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>31 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>47 per 1000<br/> (22 to 104) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.51<br/> (0.69 to 3.33) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>705<br/> (7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p>VERY LOW <sup>8 9 10</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the assumed risk is the median control group risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).<br/> CI: Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level due to serious imprecision (small sample size; confidence interval suggests both benefit and harm). </p> <p><sup>2</sup>Downgraded one level due to serious imprecision (small sample size). </p> <p><sup>3</sup>Downgraded one level due to serious risk of bias (high drop‐off and ITT was not or was not properly implemented in one of the three studies, Xia 2012). </p> <p><sup>4</sup>Downgraded one level due to serious risk of bias (blinding of outcome assessors unclear and high likelihood of attrition bias). </p> <p><sup>5</sup>Downgraded two levels due to very serious imprecision (small sample size; very wide confidence interval, suggesting appreciable benefit and harm). </p> <p><sup>6</sup>Downgraded one level due to serious risk of bias (high likelihood of attrition bias). </p> <p><sup>7</sup>Downgraded one level due to serious risk of bias (allocation concealment and blinding of outcome assessors unclear). </p> <p><sup>8</sup>Downgraded one level because of serious inconsistency (the directions of effects were inconsistent). </p> <p><sup>9</sup>Downgraded one level due to serious risk of bias (allocation concealment and blinding of outcome assessors unclear, high likelihood of attrition bias). </p> <p><sup>10</sup>Downgraded one level due to very serious imprecision (very wide confidence interval). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Chinese herbal medicine (CHM) compared with placebo for menopausal symptoms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009023-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">CHM compared with HT for menopausal symptoms</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Findings of Effectiveness (Primary Outcome)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Women with menopausal symptoms<br/> <b>Settings:</b> Outpatients<br/> <b>Intervention:</b> CHM<br/> <b>Comparison:</b> HT </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes<sup>a</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> <p><b> scores/values</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding</b> </p> <p><b> scores/values</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> HT</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> CHM</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vasomotor Symptoms <b>measured by Menopause Specific Quality of Life Questionnaire (MENQOL, monthly)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean vasomotor symptoms</p> <p>in the control groups</p> <p>ranged across control groups from<br/> 0.36 to 0.45 points, on an 0‐29 questionnaire scale </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean vasomotor symptoms was<br/> 0.47 points higher in the CHM group than in HT<br/> (0.5 lower to 1.44 higher), on an 0‐29 questionnaire scale. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>127<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.47 (‐0.50 to 1.44)</p> <p>MENQOL a 29‐item questionnaire with scale from 0 to 6. A lower score means fewer symptoms.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse Effects</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>60 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>57 per 1000<br/> (40 to 83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.96<br/> (0.66 to 1.39) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>864<br/> (6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Symptoms reported included mild diarrhoea, breast tenderness, gastric discomfort and an unpleasant taste </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).<br/> CI<b>:</b> Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> None of the included studies in this comparison assessed the following primary outcomes: frequency of daily hot flushes; frequency of daily night sweats; severity of daily hot flushes; severity of daily night sweats; overall scores of daily hot flushes; overall scores of daily night sweats measured in a diary. </p> <p><sup>1</sup>Downgraded one level due to serious imprecision (small sample size; confidence interval suggests both benefit and harm). </p> <p><sup>2</sup> Downgraded two levels due to very serious risk of bias (sequence generation, allocation concealment and blinding of outcome assessors unclear; study participants and personnel not blinded; outcome data incomplete). </p> <p><sup>3</sup>Downgraded one level due to serious imprecision (very wide confidence interval). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">CHM compared with HT for menopausal symptoms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/full#CD009023-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009023-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">CHM versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vasomotor symptoms (hot flushes/night sweats) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Frequency of hot flushes in a diary (daily)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.88, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Severity of hot flushes in a diary (daily)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐1.00, ‐0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Overall scores of hot flushes in a diary (daily)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.81 [‐2.08, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Overall scores of hot flushes in a diary (monthly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.80 [‐8.93, 3.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Overall scores of night sweats in a diary (daily)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.19, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Overall scores of night sweats in a diary (monthly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐1.76, 4.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Vasomotor symptoms measured by KI (monthly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.79 [‐5.52, ‐4.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8 Vasomotor symptoms measured by MENQOL (monthly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐1.52, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Menopausal symptoms measured monthly <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 By MENQOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 By KI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 By HFRDI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Improvement in menopausal symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [1.13, 1.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>705</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.51 [0.69, 3.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 QoL by SF‐36 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.60 [‐3.66, 24.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">CHM versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009023-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">CHM versus conventional therapy (HT)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vasomotor symptoms (hot flushes/night sweats) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [‐0.50, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vasomotor symptoms measured by MENQOL (monthly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [‐0.50, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Menopausal symptoms measured monthly <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 By MENQOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.83 [‐7.00, 3.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 By KI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>642</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.24 [‐3.99, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Improvement in menopausal symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>833</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [1.04, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>864</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.66, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 QoL by MENQOL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.42 [‐5.34, 10.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 QoL by SF‐36 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐12.95, 12.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">CHM versus conventional therapy (HT)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009023-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">CHM versus conventional therapy (fluoxetine &amp; estazolam)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.03, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">CHM versus conventional therapy (fluoxetine &amp; estazolam)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009023-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">CHM versus another CHM (different formulations)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Improvement in menopausal symptoms (general) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Improvement in menopausal symptoms (TCM diagnostic patterns) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">CHM versus another CHM (different formulations)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009023.pub2/references#CD009023-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009023.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009023-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009023-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009023-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD009023-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ru#CD009023-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009023-note-0010">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009023\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009023\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009023\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009023\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009023\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=cdmLYOAV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009023.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009023.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009023.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009023.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009023.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724461888"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009023.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724461892"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009023.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e6367af88f3fd',t:'MTc0MDcyNDQ2Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 